3-iodobenzylguanidine has been researched along with Neuroblastoma in 677 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 111 (16.40) | 18.7374 |
1990's | 210 (31.02) | 18.2507 |
2000's | 127 (18.76) | 29.6817 |
2010's | 179 (26.44) | 24.3611 |
2020's | 50 (7.39) | 2.80 |
Authors | Studies |
---|---|
Bayer, M; Bruchelt, G; Brückner, R; Bruns, M; Hampel, T; Handgretinger, R | 1 |
Fujioka, K; Godugu, K; Karakus, OO; Mousa, SA | 1 |
Braunstein, SE; DuBois, SG; Fishel Ben Kenan, R; Haas-Kogan, DA; Hawkins, RA; Matthay, KK; Polishchuk, AL | 1 |
Boeckx, N; Deroose, CM; Renard, M; Tousseyn, T; Uyttebroeck, A; Vancraeynest, E | 1 |
Applebaum, MA; Cohn, SL; Feinberg, N; Granger, M; Liu, L; Mayampurath, A; Michael, D; Naranjo, A; Ramesh, S; Volchenboum, SL | 1 |
Cho, HW; Cho, YS; Ju, HY; Koo, HH; Lee, JW; Lim, H; Seo, ES; Shin, M; Sung, KW; Yoo, KH | 1 |
Alcasabas, AP; Chantada, G; Faulkner, L; Fawzy, M; Ghandour, K; Howard, SC; Hylton, J; Khan, MS; Khattab, M; Lam, CG; Matthay, KK; Nguyen, HTK; Parikh, NS; Penumarthy, N; Saab, R; Soh, SY | 1 |
He, H; Xu, Q; Yu, C | 1 |
Jing, H; Li, F; Liu, Y; Zheng, K | 1 |
Decarolis, B; Franzius, C; Hero, B; Pfluger, T; Rogasch, JMM; Schmidt, M; Simon, T | 1 |
Clement, SC; Kremer, LCM; Tytgat, GAM; van Santen, HM; van Trotsenburg, ASP | 1 |
Kachanov, D; Kailash, C; Likar, Y; Shamanskaya, T; Yadgarov, M | 1 |
Batra, V; Carlin, S; Elias, J; Groff, D; Hou, C; Li, Y; Makvandi, M; Maris, JM; Martinez, D; Martorano, P; Pawel, B; Pryma, DA; Ranieri, P; Samanta, M; Tsang, M; Vaidyanathan, G | 1 |
Buxbaum, S; Kroiss, AS; Rossetti, LM; Uprimny, C; Virgolini, IJ | 1 |
Baruchel, S; Beiske, KH; Hero, B; Kushner, BH; Ladenstein, RL; Macy, ME; Matthay, KK; Moreno, L; Park, JR; Pearson, AD; Seibel, NL; Valteau-Couanet, D; Villablanca, JG; Wheatley, K | 1 |
Bruzoni, M; Donaldson, S; Gutkin, P; Hiniker, SM; Lansinger, O; Majzner, RG; Nadel, H; Oh, J; Sandhu, N; Shimada, H; Sodji, QH; von Eyben, R; Wang, YP | 1 |
Blom, T; Braat, AJAT; de Keizer, B; Fiocco, M; Lam, MGEH; Poot, AJ; Samim, A; Tolboom, N; Tytgat, GAM; van Noesel, MM; van Rooij, R; Viol, SLM; Windhorst, AD | 1 |
Kato, K; Kinuya, S; Nakamura, S; Sugano, H | 1 |
Bagatell, R; Diller, L; Grupp, SA; LaBarre, B; London, WB; Matthay, KK; Naranjo, A; Parisi, MT; Park, JR; Shulkin, BL; Streby, KA; Voss, SD; Yanik, GA; Yu, AL | 1 |
Atak, F; Aydın, GB; Oğuz, KK; Öncel, İ; Öz, S | 1 |
Badel, JN; Bogart, E; Corradini, N; Cougnenc, O; Courbon, F; Defachelles, AS; Deley, MCL; Gambart, M; Giraudet, AL; Kolesnikov-Gauthier, H; Oudoux, A; Rault, E; Schleiermacher, G; Sevrin, F; Valteau-Couanet, D | 1 |
Abid, K; Beck Popovic, M; Eugster, PJ; Fani, M; Gaonkar, RH; Grand-Guillaume, J; Grouzmann, E; Mansi, R; Zanger, S | 1 |
Feng, L; Lu, X; Wang, W; Yang, J | 1 |
Bán, Z; Csernus, K; Gilitsch, A; Mezősi, E; Ottóffy, G; Vojcek, Á | 1 |
Batra, V; DuBois, SG; Gikandi, A; Granger, MM; Marachelian, A; Maris, JM; Martinez, D; Matthay, KK; Park, JR; Pawel, B; Vo, KT | 1 |
Evers, R | 1 |
McHugh, K; Orr, KE | 1 |
Wen, Z; Zhuang, H | 1 |
Espinosa Muñoz, E; Lumbreras Vega, LJ; Martín García, AM; Puentes Zarzuela, C; Ramírez Ocaña, D | 1 |
Grant, CN; Olecki, E | 1 |
Anongpornjossakul, Y; Anurathapan, U; Chamroonrat, W; Chokesuwattanasakul, P; Chotipanich, C; Hongeng, S; Kositwattanarerk, A; Pakakasama, S; Pongphitcha, P; Sritara, C; Sriwatcharin, W; Thamnirat, K; Thokanit, NS; Utamakul, C | 1 |
Bal, C; Kumar, R; Pandey, AK; Santosh, Y; Sharma, PD; Yadav, D | 1 |
Jimenez, C; Núñez, R; Wendt, R | 1 |
Hosoya, Y; Iguchi, A; Manabe, A; Seigo, K; Sugiyama, M | 1 |
Garrido Magaña, E; Nishimura Meguro, E; Rivera Hernández, AJ; Silva Estrada, JA; Zurita Cruz, JN | 1 |
Aldridge, MD; Biassoni, L; Bomanji, JB; Gains, JE; Gaze, MN; Mattoli, MV; Shankar, A | 1 |
Conrad, CM; Fischer, KW; Flori, HR; Mwenesi, R; Ostwani, W; Quinn, JA; Scott, A; Yanik, GA | 1 |
Hanaoka, H; Higashi, T; Higuchi, T; Ikoma, Y; Ishioka, NS; Ohshima, Y; Sakashita, T; Sasaki, I; Tsushima, Y; Ukon, N; Watanabe, S | 1 |
Chesler, L; Gouverneur, V; Kramer-Marek, G; Martins, CD; Smith, G; Turnock, S; Turton, DR; Wilson, TC | 1 |
Harada, A; Hirobe, S; Makimoto, A; Shimojima, N; Yuza, Y | 1 |
Abdeen, N | 1 |
Bares, R; Barreuther, M; Flaadt, T; Gassenmaier, S; Lang, P; Schaefer, JF; Tsiflikas, I | 1 |
Brink, A; Burger, C; Du Plessis, J; Engelbrecht, G; Esterhuizen, TM; Hendricks, M; Janse van Vuuren, M; Kruger, M; More, S; Nyakale, N; Uys, R; van Emmenes, B; Van Heerden, J | 1 |
Cohen-Gogo, S; Irwin, MS; Morgenstern, DA; Rafael, MS; Shammas, A; Vali, R | 1 |
Körber, F; Schäfer, JF | 1 |
Wang, W; Wang, Y; Yang, J; Yang, X | 1 |
Acord, M; Alai, E; Cahill, AM; Edgar, JC; Escobar, F; Maris, JM; Mosse, YP; Pawel, B; Pogoriler, J; Samoyedny, A; Shellikeri, S; Srinivasan, A; States, L; Vatsky, S | 1 |
Berkovich, R; Cohn, SL; Czarnecki, S; DuBois, SG; Goldsmith, KC; Goodarzian, F; Granger, MM; Groshen, S; Haas-Kogan, DA; Irwin, MS; Ji, L; Marachelian, A; Maris, JM; Matthay, KK; Mosse, YP; Park, JR; Pinto, N; Shamirian, A; Shimada, H; Shusterman, S; Tsao-Wei, D; Twist, CJ; Villablanca, JG; Vo, KT; Weiss, B; Yanik, GA | 1 |
Farid, M; Koo, SX; Loh, A; Loke, KS; Soh, SY; Tong, AK | 1 |
Attinà, G; Mastrangelo, S; Ruggiero, A | 1 |
Deyell, RJ; Farfan, M; Irwin, MS; Moorehead, PC; Morgenstern, DA; Portwine, C; Rafael, MS; Shammas, A; Usmani, N; Vali, R; Vanniyasingam, T | 1 |
Berthold, F; Bleeker, GM; Caron, HN; Kraal, KC; Tytgat, GA; van Eck-Smit, BL; van Eijkelenburg, NK; van Noesel, MM | 1 |
Clement, S; Kremer, LCM; Ronckers, CM; Teepen, J; Tytgat, L; van den Heuvel-Eibrink, MM; van Santen, HM | 1 |
Bai, H; Baker, DL; Batra, V; Diskin, SJ; DuBois, SG; Kreissman, S; Maris, JM; Matthay, KK; Mody, R; Naranjo, A; Oldridge, D; Parisi, M; Park, JR; Russ, D; Shulkin, BL; Van Ryn, C; Yanik, G | 1 |
Kraal, KC; Tytgat, GA; van Dalen, EC; Van Eck-Smit, BL | 1 |
DuBois, SG; Frazier, AL; Gauguet, JM; Grant, FD; Pace-Emerson, T; Shusterman, S; Voss, SD | 1 |
Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG | 1 |
Cho, EJ; Cho, HW; Koo, HH; Lee, JW; Lee, S; Lee, SK; Lim, DH; Ma, Y; Sung, KW; Yoo, KH | 1 |
Castellano, A; D'Andrea, ML; Garganese, MC; Pizzoferro, M; Villani, MF | 1 |
Servaes, SE; Tolboom, N; Zhuang, H | 1 |
Able, S; Allen, DP; Corroyer-Dulmont, A; Falzone, N; Gaze, MN; Hill, MA; Kartsonaki, C; Kersemans, V; Kinchesh, P; Malcolm, J; Smart, SC; Thompson, J; Vallis, KA; Vojnovic, B | 1 |
Carrasquillo, JA; Hilden, P; Modak, S; Ostrovnaya, I; Pandit-Taskar, N; Zanzonico, P | 1 |
Campbell, K; Coleman, M; DuBois, SG; Edmondson, DA; Haas-Kogan, DA; Karski, EE; Kohlgruber, AC; Matthay, KK; Olow, A | 1 |
Bar-Sever, Z; Biassoni, L; Boubaker, A; Castellani, MR; Gelfand, MJ; Kreissman, SG; Ladenstein, R; Lambert, B; Lewington, V; Matthay, KK; Nadel, H; Naranjo, A; Oudoux, A; Parisi, MT; Park, JR; Pötschger, U; Shulkin, BL; Śliwińska, A; Taborska, K; Valteau-Couanet, D; Yanik, GA | 1 |
Kaji, T; Kawano, Y; Kodama, Y; Nakagawa, S; Nishikawa, T; Okamoto, Y; Rindiarti, A; Takumi, K; Tanabe, T; Yoshioka, T | 1 |
Gains, JE; Gaze, MN; Moroz, V; Sebire, NJ; Wheatley, K | 1 |
Hu, Q; Liu, AG; Liu, SY; Wang, YQ; Xia, J; Zhang, A; Zhang, H; Zhang, LQ; Zhang, XL | 1 |
Ahmadzadehfar, H; Alexander, N; Baruchel, S; Shammas, A; Vali, R | 1 |
Liu, B; Servaes, S; Zhuang, H | 2 |
Breton, M; Cellier, C; Gauthé, M; Jehanno, N; Michon, J; Sarnacki, S; Schleiermacher, G; Wartski, M | 1 |
Amthauer, H; Furth, C; Hundsdoerfer, P; Rogasch, JMM; Schatka, I; Wedel, F | 1 |
Fletcher, JI; Haber, M; Marshall, GM; Norris, MD; Trahair, TN; Ziegler, DS | 1 |
Bogart, E; Chastagner, P; Cougnenc, O; Defachelles, AS; Ferry, I; Kolesnikov-Gauthier, H; Michon, J; Oudoux, A; Proust, S; Schleiermacher, G; Valteau-Couanet, D | 1 |
Chaturvedi, A; Franco, A; Katzman, PJ | 1 |
Buchpiguel, CA; Coura-Filho, GB; Crema, KP; Oliveira, NC; Pelissoni, RA; Sapienza, MT; Willegaignon, J | 1 |
Agrawal, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
Appelbaum, D; Armato, SG; Cohn, SL; Engelmann, R; Kang, W; Lai, H; Nadel, H; Pinto, N; Pu, Y; Shulkin, BL; Sokol, EA; Starkey, A; Volchenboum, S; Yanik, GA | 1 |
Alexander, N; Baruchel, S; Batra, V; Irwin, MS; Marrano, P; Martinez, D; Naranjo, A; Thorner, P; Van Ryn, C; Zhang, L | 1 |
Adria, M; Balaguer, J; Candela-Juan, C; Cañete, A; Chimeno, JM; Ibanez-Rosello, B; Loaiza, JL; Martí-Bonmatí, L; Montoro, A; Sebastià, N; Torres-Espallardo, I | 1 |
Alfranca, A; Baeza, A; Castillo, RR; Gonzalez-Murillo, Á; Melen, GJ; Ramírez, M; Vallet-Regí, M; Villaverde, G | 1 |
Echebarria, A; Genolla, J; Llorens, V; Lopez-Almaraz, R; Minguez, P; Rodriguez, T | 1 |
Bai, X; Wang, X; Zhuang, H | 1 |
Bordbar, M; Shahriari, M; Shakibazad, N; Zareifar, S; Zekavat, OR | 1 |
Cheng, M; Peng, F; Xie, F; Zhang, H | 1 |
Cohn, SL; Kreissman, SG; London, WB; Maris, JM; Matthay, KK; McGrady, P; Naranjo, A; Parisi, MT; Park, JR; Shulkin, BL; Villablanca, JG; Yanik, GA | 1 |
Aktolun, C; Castellani, MR | 1 |
Gelfand, MJ; Parisi, MT; Sharp, SE; Shulkin, BL; Yanik, GA | 1 |
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
Charron, M | 1 |
DuBois, SG; Matthay, KK | 2 |
Bomanji, JB; Gains, JE; Gaze, MN; Walker, C | 1 |
Ash, S; Bar Shalom, R; Bar-Deroma, R; Ben Barak, A; Berniger, A; Golan, H; Goldstein, G; Houri, H; Kuten, A; Nevelsky, A; Nevo, N; Toren, A; Waldman, D; Weyl Ben-Arush, M; Yaniv, I | 1 |
Cabria, M; Cistaro, A; Conte, M; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
Boscardin, WJ; Brakeman, PR; DuBois, SG; Hawkins, RA; Matthay, KK; Wong, T | 1 |
Codreanu, I; Zhuang, H | 1 |
Atas, E; Kesik, V; Kismet, E; Koseoglu, V | 1 |
Bleeker, G; Caron, HN; de Kraker, J; Heij, HA; Schoot, RA; Tytgat, GA; van Eck, BL | 1 |
Fahey, FH; Grant, FD; Lorenzen, WA; Markelewicz, RJ; Shusterman, S; Treves, ST | 1 |
Aktolun, C; Bombardieri, E; Castellani, MR | 1 |
Clement, SC; Kremer, LC; Tytgat, GA; van Eck-Smit, BL; van Santen, HM; van Trotsenburg, AS | 1 |
Bartenstein, P; Coppenrath, E; Fendler, WP; Melzer, HI; Pfluger, T; Schmid, I; von Schweinitz, D; Walz, C | 1 |
Bleeker, G; Caron, HN; de Kraker, J; Hoefnagel, CA; Schoot, RA; Tytgat, GA; van Eck, BL | 1 |
Baldari, S; Cardile, D; Minutoli, F; Sindoni, A | 1 |
Bellersen, L; Bulten, BF; de Geus-Oei, LF; Kapusta, L; Mavinkurve-Groothuis, AM; van der Palen, RL; van Laarhoven, HW | 1 |
Clement, SC; Kraal, KC; Kremer, LC; Tytgat, GA; van den Bos, C; van Eck-Smit, BL; van Santen, HM | 1 |
Hsiao, R; Ikegaki, N; Limpar, MM; Lomahan, S; Maloney, NJ; Tang, XX; Tran, TA; Wang, SS | 1 |
Gains, JE; Gaze, MN; Moroz, V; Wheatley, K; Wilson, JS | 1 |
Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
Blasberg, RG; Cheung, NK; Guo, H; Huang, R; Lewis, JS; Thaler, HT; Zanzonico, PB; Zhang, H | 1 |
Al-Faraj, E; Gupta, A; Irwin, MS; Millar, BA | 1 |
Fuchimoto, Y; Fujimura, T; Hoshino, K; Hotta, R; Kuroda, T; Matsufuji, H; Morikawa, Y; Nakahara, T; Shimojima, N | 1 |
Behfar, M; Beiki, D; Eftekhari, M; Fallahi, B; Fard-Esfahani, A; Ghavamzadeh, A; Hamidieh, AA; Hosseini, AS; Paragomi, P; Shamshiri, A | 1 |
Bagatell, R; DuBois, SG; Haas-Kogan, DA; Hamilton, J; Hawkins, RA; Hill-Kayser, C; Lau, M; Lemons, RS; Li, R; Little, A; Marcus, KJ; Matthay, KK; Polishchuk, AL; Strahlendorf, C; Tran, HC; Weinberg, V | 1 |
Corapcoğlu, F; Demir, H; Demirsoy, U | 1 |
Codreanu, I; Servaes, S; Yang, J; Zhuang, H | 2 |
Bombardieri, E; Chiti, A; Lorenzoni, A; Pepe, G | 1 |
Ando, K; Higashimoto, Y; Hino, M; Hishiki, T; Horie, H; Iwai, J; Kakuda, H; Komatsu, S; Mitsunaga, T; Nakata, M; Ochiai, H; Okimoto, Y; Saito, T; Taneyama, Y; Terui, K; Yoshida, H; Yotsumoto, K | 1 |
Bolch, WE; DuBois, SG; Hawkins, RA; Huang, SY; Lee, C; Matthay, KK; Pampaloni, MH; Seo, Y; Sznewajs, A; Van Brocklin, HF | 1 |
Cripe, TP; Kunkler, A; Ranalli, MA; Shah, N; Streby, KA | 1 |
Coogan, A; de St Maurice, A; Frangoul, H; Williams, JV | 1 |
Aso, T; Kawamoto, H; Kono, Y; Kurihara, H; Shimizu, Y; Wakatsuki, Y; Yasui, N | 1 |
Allen-Rhoades, W; Kim, E; Krance, R; Louis, CU; Mazloom, A; Nuchtern, J; Paulino, AC; Russell, H | 1 |
Bleeker, G; Caron, HN; Hero, B; Kam, BL; Kaspers, GJ; Kreissman, SG; Lambert, B; Laureys, G; Schmidt, M; Schulte, JH; Tytgat, GA; van Eck-Smit, BL; van Noesel, MM; van Schie, A; Versteeg, R; Yanik, G; Zwinderman, KH; Øra, I | 1 |
Choi, HS; Lee, BC; Lee, WW; Park, HJ; So, Y; Suh, M | 1 |
Caron, HN; Clement, SC; Tytgat, GA; van Eck-Smit, BL; van Rijn, RR; van Santen, HM; van Trotsenburg, AS | 1 |
Allen, S; Bent, M; Courtier, J; DuBois, SG; Hawkins, R; Hilton, JF; Hollinger, F; Matthay, KK; Mosse, YP | 1 |
Courtier, J; Czarnecki, S; Goodarzian, F; Groshen, S; Haas-Koga, D; Hasenauer, CB; Hawkins, R; Hutchinson, R; Jackson, H; Katzenstein, HM; Marachelian, A; Maris, JM; Matthay, KK; Park, JR; Shimada, H; Shulkin, BL; Tsao-Wei, D; Villablanca, JG; Weiss, B; Yanik, GA | 1 |
Chen, E; Cohn, SL; Courtier, J; Czarnecki, S; DuBois, SG; Geier, E; Giacomini, K; Goodarzian, F; Granger, MM; Groshen, S; Haas-Kogan, DA; Hawkins, R; Jackson, H; Marachelian, A; Matthay, KK; Park, JR; Shimada, H; Tsao-Wei, D; Villablanca, JG; Weiss, B; Yang, X; Yanik, GA | 1 |
Bai, X; Yang, H; Zhuang, H | 1 |
Hayashi, H; Hishiki, T; Mitsunaga, T; Nakata, M; Saito, T; Terui, K; Yoshida, H | 1 |
Kayano, D; Kinuya, S | 1 |
Choi, J; Hens, M; Koumarianou, E; McDougald, D; Vaidyanathan, G; Zalutsky, MR | 1 |
Caron, HN; Kam, B; Kraal, KC; Tytgat, GA; van Eck-Smit, BL; van Noesel, M | 1 |
Agarwala, S; Bakhshi, S; Bal, C; Bhatnagar, V; Dhull, VS; Kumar, R; Kundu, P; Patel, C; Sharma, P | 1 |
Coleman, J; Pai Panandiker, AS; Shulkin, B | 1 |
Delgado, A; Flux, G; Fombellida, JC; Genollá, J; Guayambuco, S; Mínguez, P; Sjögreen Gleisner, K | 1 |
Bartenstein, P; Coppenrath, E; Fendler, WP; Ilhan, H; Pfluger, T; Schmid, I; Thornton, HI; von Schweinitz, D; Wenter, V | 1 |
Doral, MY; DuBois, SG; Matthay, KK; Villablanca, JG; Yanik, GA; Zhou, MJ | 1 |
Downie, P; Eu, P; Hicks, RJ; Hofman, MS; Hogg, A; Kong, G; Murray, WK; Super, L; Wilson, S; Wood, P | 1 |
Arnone, G; Caobelli, F; Cistaro, A; Coppolino, P; Ficola, U; Paratore, R; Piccardo, A; Quartuccio, N; Sperandeo, A | 1 |
DuBois, SG; Giacomini, K; Gustafson, WC; Hogarty, M; Kim, GE; Kreissman, SG; Lin, L; Matthay, KK; Mendelsohn, L; Naranjo, A; Nekritz, E; Temple, W; Van Ryn, C; Yanik, GA | 1 |
Bai, X; Zhuang, H | 2 |
Adam, JA; Bleeker, G; Caron, HN; Hooft, L; Kremer, LC; Tytgat, GA; van Dalen, EC | 1 |
DuBois, SG; Hawkins, RA; Marachelian, A; Matthay, KK; Nardo, L; Park, JR; Pon, E; Trieu, M; Twist, CJ | 1 |
de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M | 1 |
DuBois, SG; Gustafson, C; Hawkins, R; Lee, JS; Matthay, K; Roy-Burman, A; Wong, T; Wu, R | 1 |
Carrasquillo, JA; Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Modak, S; Pandit-Taskar, N; Zanzonico, P | 1 |
Chittenden, S; Denis-Bacelar, AM; Du, Y; Falzone, N; Flux, GD; George, SL; Kirk, SJ; Lancaster, D; Mandeville, H; Meller, ST; Pearson, AD; Saran, F; Vaidya, SJ | 1 |
Servaes, S; Zhang, W; Zhuang, H | 1 |
Carpentier, P; Clisant, S; Cougnenc, O; Defachelles, AS; Kolesnikov-Gauthier, H; Lervat, C; Oudoux, A | 1 |
Flux, G; Gleisner, KS; Gustafsson, J; Mínguez, P | 1 |
Černý, I; Kašpárková, H; Prášek, J | 1 |
Eslamy, H; Parisi, MT; Park, JR; Shulkin, BL; Yanik, GA | 1 |
Basu, E; Chu, B; Modak, S; Santopolo, S | 1 |
Bayer, M; Bruchelt, G; Dittmann, H; Handgretinger, R; Sauter, AW; Schmitt, J | 1 |
DuBois, SG; Lee, JS; Matthay, K; Roy-Burman, A | 1 |
Allen, S; Coleman, MA; DuBois, SG; Edmondson, DA; Hartmann, CL; Karski, EE; Kohlgruber, A; Koneru, H; Matthay, KK; Peterson, LE | 1 |
Alazraki, A; Hayes, LL; Jones, RA; Palasis, S; Porter, DA; Wasilewski-Masker, K | 1 |
Batra, V; DuBois, SG; Fetzko, S; Huibregtse, KE; Marachelian, A; Maris, JM; Matthay, KK; Neuhaus, J; Vo, KT; Weiss, B; Yanik, GA | 1 |
Batra, V; Elias, J; Makvandi, M; Maris, JM; Patel, N; Pryma, DA; Zuppa, AF | 1 |
Castellani, R; Drobics, M; Giammarile, F; Ladenstein, R; Lambert, B; Lewington, V; Lynch, T; McEwan, AJB; Poetschger, U; Sever, ZB; Shulkin, B; Staudenherz, A | 1 |
Alazraki, A; Cash, T; Katzenstein, HM; Qayed, M | 1 |
Shao, F; Xie, P; Zhuang, H | 1 |
Aldridge, MD; Chua, S; Flux, G; Fowkes, L; Gear, J; Gregory, RA; Levine, D; Murray, I; Waddington, WA | 1 |
Edwards, K; Monaghan, R; Shao, F; Xie, P; Zhuang, H | 1 |
Kang, ES; Koo, HH; Lee, JW; Lee, SH; Sung, KW; Yi, E; Yoo, KH | 1 |
Al-Sayegh, H; Bagatell, R; Diller, L; DuBois, S; Haas-Kogan, DA; Hawkins, R; Hill-Kayser, C; Lee, SW; Li, R; London, WB; Marcus, KJ; Matthay, KK; Polishchuk, A; Shusterman, S | 1 |
Han, S; Koh, KN; Lee, JJ; Yoo, SH | 1 |
Zheng, K; Zhuang, H | 1 |
Pfluger, T; Piccardo, A | 1 |
Gaze, MN | 2 |
Cammilleri, S; Colavolpe, C; Coze, C; Guedj, E; Mundler, O; Taïeb, D | 1 |
Frame, B; Huberty, JP; Koral, KF; Maris, JM; Matthay, KK; Normolle, D; Regan, D; Yanik, GA | 1 |
Babich, JW; Boyd, M; Gaze, MN; Mairs, RJ; McCluskey, AG; Pimlott, SL | 1 |
Ialfimov, AN; Ivanova, AA; Savchenko, ON; Sokolov, AV | 1 |
Alonso, O; Gambini, JP; Hermida, JC; Heuguerot, C; López Lerena, JJ; Quagliata, A | 1 |
Barnes, N; Kokai, G; Losty, P; Mc Dowell, H | 1 |
Bischof Delaloye, A; Boubaker, A | 2 |
Dubois, S; Matthay, KK; Taggart, D | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
Brophy, P; Franc, BL; Groshen, S; Hawkins, RA; Huberty, J; Jackson, H; Maris, JM; Matthay, KK; Quach, A; Shusterman, S; Veatch, J; Villablanca, JG; Yanik, G | 1 |
Castel, V; Farto, JC; Heiba, S; Jacobson, AF; Kadota, R; Khutoryansky, N; Pfluger, T; Serafini, A; Tulchinsky, M; Tumeh, S; Vik, TA | 1 |
Herman, TE; Siegel, MJ | 1 |
Morrow, T | 1 |
Bayer, M; Bruchelt, G; Dittmann, H; Gründemann, D; Handgretinger, R; Kuçi, Z; Schömig, E | 1 |
Amato, G; Di Maggio, G; Ferrara, F; Garzi, A; Messina, M; Molinaro, F | 1 |
Cross, SF; Dalla Pozza, L; Munns, CF | 1 |
Furman, WL; Gelfand, MJ; Salisbury, S; Sharp, SE; Shulkin, BL | 1 |
Békássy, AN; Dykes, JH; Garkavij, M; Gleisner, KS; Juliusson, G; Lenhoff, S; Ora, I; Scheding, S; Tennvall, J; Toporski, J; Turkiewicz, D | 1 |
Akhurst, TJ; Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
Buckley, SE; Chittenden, SJ; Flux, GD; Meller, ST; Saran, FH | 1 |
Carlson, D; Groshen, S; Han, MM; Hawkins, R; Jackson, HA; Mari Aparici, C; Maris, J; Matthay, KK; Quach, A; Taggart, DR; Villablanca, JG; Ye, W | 1 |
Barbaric, D; Cohn, RJ; Marshall, GM; O'Brien, TA; Russell, SJ; Satharasinghe, K; Trahair, TN; Ziegler, DS | 1 |
Chiang, TC; Shen, LH; Yang, AS | 1 |
Heston, TF | 1 |
Bhatla, D; Nguyen, NC; Osman, MM | 1 |
El-Maghraby, T | 1 |
Ezziddin, S; Grünwald, F | 1 |
Berthold, F; Eschner, W; Schicha, H; Schmidt, M; Simon, T; Sudbrock, F | 1 |
Cheung, NK; Modak, S | 1 |
Black, RR; Deng, H; Jacobson, AF; Lessig, HJ; Lombard, J | 1 |
Cohn, SL; Giammarile, F; Ladenstein, R; Lewington, V; Matthay, KK; Michon, J; Pearson, AD; Shulkin, B | 1 |
Aigner, T; Bierbach, U; Kluge, R; Metzger, R; Sabri, O; Sattler, B; Simon, T; Till, H; Wachowiak, R | 1 |
Babich, JW; Barrett, JA; Boyd, M; Femia, FJ; Hillier, SM; Joyal, JL; Kronauge, JF; Mairs, RJ; Maresca, KP | 1 |
Cohn, R; Pereira, J; Rossleigh, M; Schindler, T; Yu, C | 1 |
Benesch, M; Lackner, H; Nebl, A; Schmidt, S; Schwinger, W; Sovinz, P; Urban, C | 1 |
Llamas, JM; Mena, LM; Moreno, MJ; Muros, MA; Palacios, H; Santiago, A | 1 |
Coppenrath, E; Pflüger, T; Schmid, I; Weiss, M | 1 |
Baum, RP; Howman-Giles, R; Schmidt, M; Simon, T | 1 |
Fitzgerald, P; Franc, B; Groshen, S; Hawkins, RA; Huberty, J; Ji, L; Maris, JM; Matthay, KK; Mishra, V; Quach, A; Sposto, R; Sznewajs, A; Veatch, J; Villablanca, JG; Wei, D; Yanik, G | 1 |
Parisi, MT; Stanescu, LA | 1 |
Stebbins, M | 1 |
Hara, T; Kinoshita, Y; Koga, Y; Kohashi, K; Masumoto, K; Nakagawara, A; Oda, Y; Ohira, M; Souzaki, R; Suminoe, A; Taguchi, T; Tajiri, T; Tanaka, S | 1 |
Fukuoka, M; Kinuya, S; Mochizuki, T; Taki, J | 1 |
Decristoforo, C; Gabriel, M; Kendler, D; Kranewitter, C; Kroiss, A; Putzer, D; Santner, W; Uprimny, C; Virgolini, IJ; Waitz, D; Warwitz, B | 2 |
Kreissman, SG; London, WB; Matthay, KK; Naranjo, A; Parisi, MT; Shulkin, BL; Yanik, GA | 1 |
Di Giannatale, A; Mastrangelo, S; Riccardi, R; Rufini, V; Ruggiero, A | 1 |
Dubois, SG; Haas-Kogan, D; Hawkins, R; Matthay, KK; Polishchuk, AL | 1 |
Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
Dubois, SG; Geier, EG; Giacomini, KM; Haas-Kogan, DA; Itsara, M; Matthay, KK; More, SS; Mueller, S; Seo, Y; Tadano, MK; Vanbrocklin, HF; Weiss, WA; Yang, X | 1 |
Borrego Dorado, I; Cuenca Cuenca, JI; Fernández López, R; Marín Oyaga, VA; Tirado Hospital, JL; Vázquez Albertino, R | 1 |
Baniewicz, D; Johnson, K; Maris, JM; McGlynn, B; Mosse, YP; Saggio, J; Zhuang, H | 1 |
Carpentier, P; Cougnenc, O; Défachelles, AS | 1 |
Albert, MH; Bartenstein, P; Coppenrath, E; Melzer, HI; Pfluger, T; Schmid, I; Tudball, C; von Schweinitz, D | 1 |
Davis, RT; Drubach, LA; Fahey, FH; Grant, FD; Laffin, S; Lorenzen, W; Shusterman, S; Treves, ST | 1 |
Gelfand, MJ; Sharp, SE; Shulkin, BL | 1 |
Ames, MM; Buhrow, SA; Cohn, SL; Jackson, H; Kitchen, BJ; London, WB; McGovern, RM; McGrady, P; Naranjo, A; Parisi, MT; Reid, JM; Reynolds, CP; Shulkin, B; Sondel, PM; Stranzinger, E; Villablanca, JG; Yanik, GA | 1 |
Altrinetti, V; Bianchi, P; Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
Cho, SY; Udall, D | 1 |
Bomanji, JB; Cork, NJ; Gaze, MN; Kosmin, MA; Shankar, A | 1 |
Dannoon, SF; Gustafson, WC; Haas-Kogan, DA; Hernandez-Pampaloni, M; Lee, CL; Matthay, KK; Murphy, ST; Nekritz, EA; Seo, Y; VanBrocklin, HF; Weiss, WA | 1 |
Chesler, L; DuBois, SG; Goodarzian, F; Groshen, S; Hawkins, R; Marachelian, A; Maris, JM; Matthay, KK; Mosse, YP; Shimada, H; Stewart, C; Tagen, M; Tsao-Wei, D; Villablanca, JG; Yanik, G | 1 |
Hopman, SM; Nieveen van Dijkum, EJ; Tytgat, GA; van de Wetering, MD; van der Steeg, AF; van Eck-Smit, BL; van Santen, HM; van Trotsenburg, AS | 2 |
Hosoi, H; Iehara, T; Matsushima, S; Nishimura, T; Okuyama, C; Sano, Y; Yamada, K | 1 |
George, RE; Matthay, KK; Yu, AL | 1 |
Acharya, J; Chang, PT; Gerard, P | 1 |
Babich, JW; Boyd, M; Champion, S; Gaze, MN; Mairs, RJ; McCluskey, AG; Pimlott, SL; Tesson, M | 1 |
Babich, J; Barrett, J; Daldrup-Link, H; Dubois, SG; Goodarzian, F; Groshen, S; Hawkins, R; Jackson, H; Lafrance, N; Maris, JM; Matthay, KK; Panigrahy, A; Shimada, H; Stubbs, J; Towbin, A; Tsao-Wei, D; Villablanca, JG; Weiss, B; Yanik, GA | 1 |
Teszler, CB | 1 |
Karayalcin, B; Koç, ZP | 1 |
Amanie, J; Cho, J; Janicki, C; Loebenberg, R; McEwan, A; McQuarrie, S; Riauka, T; Roa, WH; Sloboda, R; Wiebe, L; Yaremko, B; Yee, D | 1 |
DuBois, SG; French, S; Granger, M; Hawkins, R; Horn, B; Matthay, K; Pass, A; Plummer, E | 1 |
Arisaka, O; Fukuoka, M; Fukushima, K; Hagisawa, S; Inaki, A; Kayano, D; Kinuya, S; Kurosawa, H; Nakamura, A; Okuya, M; Sato, Y; Sugita, K; Wakabayashi, H | 1 |
Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS | 1 |
Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
Gelfand, MJ; Lemen, L; Morris, VR; Turpin, BK; Weiss, BD | 1 |
Berthold, F; Decarolis, B; Dietlein, M; Hero, B; Roels, F; Schmidt, M; Schneider, C; Simon, T; Volland, R | 1 |
Christakopoulou, I; Ilias, I; Panoutsopoulos, G; Parcharidou, A | 1 |
Blake, M; Bushnell, D; Graham, MM; Johnson, J; Juweid, ME; Madsen, M; Menda, Y; O'Dorisio, MS | 1 |
Siegel, JA; Sparks, RB; Stabin, MG | 1 |
Bertolazzi, L; De Bernardi, B; Di Cataldo, A; Gambini, C; Garaventa, A; Haupt, R; Pizzitola, MR; Villavecchia, G | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeh, SD | 1 |
Chittenden, SJ; Flower, MA; Flux, GD; Guy, MJ; Meller, ST; Papavasileiou, P; South, C | 1 |
Charron, M; Hahn, K; Shulkin, BL | 1 |
Bunko, H; Kinuya, S; Li, XF; Michigishi, T; Mori, H; Shiba, K; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
Asselain, B; Edeline, V; Hartmann, O; Lumbroso, J; Matthay, KK; Michon, J; Tanguy, ML; Valteau-Couanet, D; Zucker, JM | 1 |
de Kraker, J; de Vijlder, JJ; van Eck, BL; van Santen, HM; Vulsma, T | 2 |
Accorsi, R; Charron, M; Maris, JM; Morowitz, MJ | 1 |
Board, J; Carlin, S; Caron, HN; Ellershaw, C; Estlin, C; George, RE; Hoefnagel, CA; Lunec, J; Mairs, RJ; McCluskey, AG; Montaldo, PG; Pearson, AD; Ponzoni, M; Sprigg, A; Tweddle, DA; Tytgat, GA; van den Brug, MD; van Eck-Smit, BL | 1 |
Brophy, P; Charron, M; Evans, AE; Heyman, S; Hickeson, M; Kang, TI; Maris, JM | 1 |
Cañete, A; Castel, V | 1 |
Brophy, P; Charron, M; Hickeson, MP; Kang, TI; Khan, J; Maris, JM; Nevrotski, T; Zhuang, H | 1 |
Abe, K; Hashimoto, T; Koizumi, K; Nishina, T | 1 |
Balistreri, L; Brophy, P; Schmus, C | 1 |
Ahlman, H; Bernhardt, P; Forssell-Aronsson, E; Jakobsen, AM; Kölby, L; Nilsson, O | 1 |
Charron, M; DuBois, SG; Glidden, DV; Hawkins, R; Huberty, J; Maris, JM; Matthay, KK; Messina, J; Veatch, J | 1 |
Gelfand, MJ | 2 |
Friedman, HS; Snyder, S; Vaidyanathan, G; Vitorello, KC; Welsh, PC; Zalutsky, MR | 1 |
Affleck, DJ; Alston, KL; Vaidyanathan, G; Welsh, P; Zalutsky, MR | 1 |
Fukuda, H; Hakamatsuka, T; Ito, H; Kaneta, T; Maruoka, S; Takahashi, S; Yamada, S | 1 |
Bardo, DM; Cohn, SL; Haut, PR; Katzenstein, HM; Kletzel, M; Liu, D; Olszewski, M; Rademaker, AW; Schmoldt, J; Shore, RM | 1 |
Cheng, SC; Hawkins, RA; Howard, JP; Huberty, JP; Kersun, LS; Maris, JM; Matthay, KK | 1 |
Baruchel, S; Das, B; He, Y; Kumar, P; Reilly, RM; Wiebe, L | 1 |
Affleck, DJ; Vaidyanathan, G; Zalutsky, MR | 2 |
Borght, TV; Krug, B; Lacrosse, M; Luyx, D; Pirson, AS; Tuerlinckx, D | 1 |
Menda, Y; O'Dorisio, MS; Pashankar, FD | 1 |
Bergeron, C; Bernard, F; Boneu, A; Bouzy, J; Chastagner, P; Coze, C; Hartmann, O; Michon, J; Perel, Y; Plantaz, D; Rodary, C; Rubie, H; Valteau-Couanet, D | 1 |
Choi, SH; Ghim, T; Goo, HW; Moon, HN; Seo, JJ | 1 |
Chang, YC; Flux, GD; Gaze, MN; Mairs, RJ; Meller, ST; Saran, FH | 1 |
Boyd, M; Gaze, MN; Mairs, RJ; McCluskey, AG | 1 |
de Kraker, J; van Santen, HM; Vulsma, T | 1 |
Claviez, A; Czech, N; Hero, B; Hufnagel, M; Schmidt, M | 1 |
Borson-Chazot, F; Giammarile, F | 1 |
Boyd, M; Cosimo, E; Fullerton, NE; Mairs, RJ | 1 |
Angerson, WJ; Boyd, M; Clark, AM; Cosimo, E; Gaze, MN; Mairs, RJ; McCluskey, AG; Ross, SC | 1 |
Cohen, M; Siddiqui, A | 1 |
Franc, B; Groshen, S; Horn, B; Maris, JM; Matthay, KK; Reynolds, CP; Seeger, RC; Tan, JC; Twomey, E; Veatch, J; Villablanca, JG; Yanik, GA | 1 |
Charron, M; Cheng, SC; Franc, BL; Hawkins, RA; Maris, JM; Matthay, KK; Messina, JA; Shulkin, B; To, B; Yanik, G | 1 |
Cheung, NK; Kushner, BH | 1 |
Baum, RP; Calcagni, ML; Rufini, V | 1 |
Divgi, CR; Meirelles, GS; Pryma, DA; Ravizzini, G | 1 |
Berthold, F; Bongartz, R; Dietlein, M; Eschner, W; Hero, B; Schicha, H; Schmidt, M; Simon, T; Sudbrock, F | 1 |
Applegate, K; Lee, ND; McGarvey, CK; Sokol, DK | 1 |
Eschner, W; Hero, B; Schicha, H; Schmidt, M; Simon, T; Sudbrock, F | 1 |
Hellström, PM; Jacobsson, H; Kogner, P; Larsson, SA | 1 |
Aoyama, C; Hosoya, R; Kamiya, T; Kato, I; Manabe, A; Ogawa, C; Ozawa, M; Takahashi, H; Takusagawa, A; Yokoyama, K | 1 |
Caron, HN; van den Berg, H | 1 |
Brophy, P; Cheng, SC; Goldsby, R; Hawkins, RA; Huberty, J; Kersun, LS; Maris, JM; Matthay, KK; Messina, J; Quach, A; Veatch, J; Yanik, G | 1 |
Bodei, L; Brans, B; Giammarile, F; Luster, M; Maecke, HR; Oyen, WJ; Tennvall, J | 1 |
Buckley, SE; Chittenden, S; Flux, GD; Gaze, MN; Lancaster, D; Partridge, M; Pearson, A; Saran, FH | 1 |
Barsaoui, S; Ben Brahim, H; Gharssallah, L; Hammami, H; Hassine, L; Mhiri, A; Oubich, F; Sellem, A | 1 |
Bae, JS; Choe, YS; Jung, KH; Kim, BT; Ko, BH; Lee, EJ; Lee, KH; Paik, JY | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Larson, S; Modak, S; Pandit-Taskar, N; Smith-Jones, P | 1 |
Caron, HN; de Kraker, J; Hoefnagel, KA; van Eck, B; van Santen, HM; Verschuur, AC | 1 |
Arsos, G; Karakatsanis, C; Koliouskas, D; Moralidis, E; Papakonstantinou, E | 1 |
Abd El-Aal, H | 1 |
Chisin, R; Klein, M; Koplewitz, BZ; Krausz, Y; Revel-Vilk, S; Rozovsky, K; Weintraub, M | 1 |
Berthold, F; Hero, B; Schicha, H; Schmidt, M; Simon, T | 1 |
Franzius, C; Hahn, K; Hero, B; Pfluger, T; Schmidt, M | 1 |
Dopfer, R; Eibach, E; Feine, U; Grumbach, S; Klingebiel, T; Meinke, J; Müller-Schaumburg, W; Niethammer, D; Treuner, J | 1 |
Hotze, A; Mahlstedt, J; Pichl, J; Wolf, F | 1 |
Mussa, GC; Silvestro, L | 1 |
Ablin, AR; Engelstad, BL; Gooding, CA; Hattner, RS; Huberty, JP | 1 |
Brandeis, WE; Bubeck, B; Eisenhut, M; Hermann, HJ; Kimmig, B; zum Winkel, K | 1 |
Beijnen, JH; Hoefnagel, CA; Maes, RA; Maessen, HJ; Nortier, YL; Rosing, H; Taal, BG; Wafelman, AR | 1 |
Barrett, A; Gaze, MN; Livingstone, A; Mairs, RJ; Wheldon, TE | 1 |
Cunningham, S; Gaze, MN; Mairs, RJ; O'Donoghue, JA; Owens, J; Russell, J; Vaidyanathan, G; Zalutsky, MR | 1 |
Cornelissen, J; Elzinga, L; Van den Bogert, C; Van Gennip, AH; Van Kuilenburg, AB; Voûte, PA; Wanders, RJ | 1 |
Iavarone, A; Lasorella, A; Mastrangelo, S; Riccardi, R; Servidei, T | 1 |
Beck, J; Bruchelt, G; Gebhardt, S; Gekeler, V; Lode, HN; Niethammer, D; Seitz, G | 1 |
De Kraker, J; Hoefnagel, CA; Tiel-van Buul, MM; van der Kleij, AJ; Van Gennip, H; Voûte, PA | 1 |
Caron, H; De Kraker, J; Heij, HA; Hoefnagel, CA; Valdés Olmos, RA; Voûte, PA; Zsiros, J | 1 |
Lasorella, A; Mancini, A; Mastrangelo, R; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L | 1 |
Mairs, RJ; Zalutsky, MR | 1 |
Abrahamsen, J; Frederiksen, PB; Helgestad, J; Lyck, B | 1 |
Beck, D; Delaloye, AB; Hadj-Djilani, NL; Laurini, R; Lebtahi, NE | 1 |
Howman-Giles, R; Shaw, PJ; Uren, RF | 1 |
Bolster, AA; Hilditch, TE; Wheldon, TE | 1 |
Jakobson, Å; Letocha, H; Martinsson, U; Nilsson, S; Strang, P; Westlin, JE | 1 |
Barrett, A; Gaze, MN; Hilditch, TE; McNee, SG; O'Donoghue, JA; Simpson, E; Wheldon, TE | 1 |
Ady, N; Asselain, B; Bonnin, F; Edeline, V; Gongora, R; Manil, L; Michon, J; Zucker, JM | 1 |
Anderson, K; Dopfer, R; Gillies, SD; Handgretinger, R; Klingebiel, T; Lang, P; Neithammer, D; Reisfeld, RA; Reuland, P; Schrappe, M | 1 |
D'Addabbo, A; D'Addabbo, F; Lauriero, F; Rubini, D; Rubini, G; Schettini, F | 1 |
Carbone, R; Cornaglia Ferraris, P; Montaldo, PG; Ponzoni, M | 1 |
Armour, A; Cunningham, SH; Gaze, MN; Mairs, RJ; McKellar, K; Owens, J; Russell, J | 1 |
Bass, JC; Gross, MD; Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC | 1 |
Barrett, A; Bolster, AA; Gaze, MN; Hilditch, TE; Wheldon, TE | 1 |
De Kraker, J; Hoefnagel, CA; Valdés Olmos, RA; Voûte, PA | 2 |
Bito, S; Dan, Y; Hino, M; Ikekubo, K; Ito, H; Masui, Y; Ohta, K; Ootsuka, H; Saiki, Y; Yamaguchi, H | 1 |
Hattner, RS; Matthay, KK; Pounds, TR | 1 |
Barbaroux, C; Brixy, F; Manil, L; Perdereau, B | 1 |
Advani, SH; Kurkure, PA; Murugesan, S; Noronha, OP; Samuel, AM; Sonawane, GA | 1 |
Elgazzar, AH; Gelfand, MJ; Golsch, GJ; Kriss, VM; Masters, PR | 1 |
Dopfer, R; Handgretinger, R; Herter, M; Klingebiel, T; Lang, P; Niethammer, D; Scheel-Walter, H | 1 |
Gaze, MN; Mairs, RJ; Vaidyanathan, G; Zalutsky, MR | 1 |
Bihl, H; Dörr, U; Koscielniak, E; Sautter-Bihl, ML; Schilling, FH; Treuner, J | 1 |
Bihl, H; Dörr, U; Sautter-Bihl, ML; Schilling, F; Treuner, J | 1 |
Cohen, MD | 1 |
Furukawa, T; Goto, M; Iijima, A; Koizumi, M; Kurosawa, H; Kurumada, H; Sawada, H; Sugita, K; Watari, T | 1 |
Gaze, MN; Hamilton, TG; Mairs, RJ | 1 |
Caracò, C; Casale, F; di Tullio, MT; Indolfi, P; Lastoria, S; Maurea, S; Salvatore, M | 1 |
Donfrancesco, F; Mastrangelo, R; Riccardi, R; Rufini, V; Troncone, L; Turba, R | 1 |
Armour, A; Gaze, MN; Mairs, RJ; Wheldon, TE | 1 |
Carey, JE; Hutchinson, RJ; Normolle, DP; Shapiro, B; Sisson, JC; Zasadny, KR; Zempel, SA | 1 |
Borrone, C; Claudiani, F; Garaventa, A; Garibaldi, L; Picco, P | 1 |
Beijnen, JH; Maes, RA; Nortier, YL; Rosing, H; Underberg, WJ; Wafelman, AR | 1 |
Bonnin, F; Hartmann, O; Lumbroso, J; Parmentier, C; Tenenbaum, F | 1 |
Alvisi, P; Fagioli, G; Galli, A; Mancini, AF; Rosito, P; Turba, E | 1 |
Berg, BO; Hattner, RS; Matthay, KK; Parisi, MT; Sandler, ED | 1 |
Behar, C; Bonnin, F; Couanet, D; Hartmann, O; Labreveux de Cervens, C; Lemerele, J; Lumbroso, J; Martelli, H; Valteau-Couanet, D | 1 |
Elgazzar, AH; Gelfand, MJ; Golsch, GJ; Harris, RE; Masters, PR; Paltiel, HJ; Washburn, LC | 1 |
Coutris, G; Mensch, B; Montravers, F; Sarda, L; Talbot, JN | 1 |
Benoit, Y; Lippens, M; Obrie, E; Osmanagaoglu, K; Schelstraete, K; Simons, M | 1 |
Caracò, C; Casale, F; di Tullio, MT; Indolfi, P; Lastoria, S; Maurea, S; Maurelli, L; Salvatore, M; Vergara, E | 1 |
Arnberg, H; Letocha, H; Nilsson, S; Påhlman, S; Westlin, JE | 1 |
Briançon, C; Clerc, J; Fourré, C; Fragu, P; Halpern, S; Jeusset, J; Omri, F | 1 |
Dessner, DA; DiPietro, MA; Shulkin, BL | 1 |
Iavarone, A; Lasorella, A; Mastrangelo, R; Riccardi, R; Servidei, T | 2 |
Vaidyanathan, G; Zalutsky, MR | 1 |
Hattner, RS; Parisi, MT | 1 |
Edeling, CJ | 1 |
Buitenhuis, C; Rutgers, M; Smets, LA; Tytgat, GA; Verwijs-Janssen, M; Voûte, PA | 1 |
Shapiro, B | 2 |
Danza, F; Iavarone, A; Lasorella, A; Mastrangelo, R; Riccardi, R; Rufini, V; Troncone, L | 1 |
Friedman, HS; Strickland, DK; Vaidyanathan, G; Zalutsky, MR | 1 |
Bolster, AA; Hilditch, TE | 1 |
Aubert, B; Giammarile, F; Hartmann, O; Lumbroso, J; Parmentier, C; Ricard, M; Schlumberger, M | 1 |
Baro, ME; Castle, VP; Dole, MG; Hutchinson, RJ; Mitchell, DS; Rawwas, JB; Shulkin, BL; Sisson, JC; Ungar, DR; Wieland, DM | 1 |
Adanja, G; Han, R; Ivanovski, P; Kovacić, K; Maksimović, L; Mitrović, S; Zagar, I | 1 |
Giammarile, F; Lumbroso, J; Olier, AL | 1 |
Bohdiewicz, PJ; Fink-Bennett, D; Gallegos, E | 1 |
Andrich, MP; Majd, M; Movassaghi, N; Shalaby-Rana, E | 2 |
Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
Boneu, A; Hartmann, O; Hattchouel, JM; Lumbroso, J; Robert, A; Rodary, C; Rubie, H; Suc, A | 1 |
Friedman, HS; Keir, ST; Vaidyanathan, G; Zalutsky, MR | 2 |
Borrone, C; Claudiani, F; De Bernardi, B; Garaventa, A; Gattorno, M; Picco, P | 1 |
Castle, VP; Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC; Yanik, GA | 1 |
Alaamer, AS; Fleming, JS; Lewington, VJ; Tristam, M; Zivanovic, MA | 1 |
Edeline, V; Lequen, H; Lumbroso, J; Manil, L; Zucker, JM | 1 |
Garaventa, A; Guarnaccia, F; Montaldo, PG; Pistoia, V; Ponzoni, M; Raffaghello, L | 1 |
Gaze, MN; Wheldon, TE | 1 |
Bihl, H; Sautter-Bihl, ML | 1 |
Fisher, GA; Rufini, V; Shapiro, B; Shulkin, BL; Sisson, JC | 1 |
de Kraker, J; Heij, HA; van Hasselt, EJ; Vos, A; Voûte, PA | 1 |
Edeline, V; Lavocat, C; Lequen, H; Manil, L; Michon, J; Neuenschwander, S; Zucker, JM | 1 |
Babich, JW; Fischman, AJ; Graham, WA | 1 |
Akin, H; Burak, Z; Erdem, S; Ozcan, Z; Ozkiliç, H | 1 |
Aslam, A; Perkins, AC; Spicer, RD | 1 |
Fielding, SL; Flower, MA | 1 |
van der Kleij, AJ; Voûte, PA | 1 |
Senekowitsch-Schmidtke, R; Weber, J; Weber, W | 1 |
Jürgens, H; Kohnert, K; Lerch, H; Schober, O; Thelen, M | 2 |
Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 2 |
Han, R; Mitrovic, S; Zagar, I | 1 |
Bonnin, F; Giammarile, F; Hartmann, O; Lumbroso, J; Parmentier, C | 1 |
Bertolazzi, L; Cabria, M; Claudiani, F; Conte, M; De Bernardi, B; Garaventa, A; Lanino, E; Scopinaro, G; Stimamiglio, P; Villavecchia, GP | 1 |
De Sio, L; Deb, G; Di Giuda, D; Donfrancesco, A; Giordano, A; Petrone, A; Rufini, V; Troncone, L | 1 |
Bertolazzi, L; Cabria, M; Claudiani, F; Conte, M; De Bernardi, B; Garaventa, A; Nigro, M; Pianca, C; Stimamiglio, P; Villavecchia, GP | 1 |
Luzi, S; Mastrangelo, R; Riccardi, R; Rufini, V; Troncone, L | 1 |
Calcagni, ML; Chinol, M; Franceschini, R; Pecorale, A; Riccardi, R; Servidei, T; Troncone, L | 1 |
Diociaiuti, L; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L | 1 |
Kuroda, T; Mizutani, S; Nakano, M; Saeki, M | 1 |
de Kraker, J; Heij, HA; Rutgers, EJ; Vos, A | 1 |
Strickland, DK; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
Giammarile, F | 2 |
Diociaiuti, L; Iavarone, A; Lasorella, A; Mastrangelo, R; Mastrangelo, S; Pession, A; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L | 1 |
Cornelissen, J; Tytgat, GA; van den Brug, M; van Gennip, AH; van Kuilenburg, AB; Voûte, PA | 1 |
Di Stefano, C; Fioretti, D; Franceschini, R; Lavitrano, M; Mastrangelo, S; Riccardi, A; Riccardi, R; Servidei, T; Tornesello, A | 1 |
Armour, A; Cunningham, SH; Gaze, MN; Mairs, RJ; Wheldon, TE | 1 |
Driver, I; Lewis, IJ; Schwarz, KB; Taylor, RE | 1 |
Babich, JW; Fischman, AJ; Graham, W | 1 |
Beijnen, JH; Hoefnagel, CA; Maes, RA; Maessen, HJ; Wafelman, AR | 1 |
Bollen, A; Franks, LM; Matthay, KK; Seeger, RC; Stram, DO | 1 |
Chauvot, P; Giammarile, F | 1 |
Larsen, RH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
Cornelissen, J; Van Gennip, AH; Van Kuilenburg, AB; Voûte, PA | 1 |
de Kraker, J; Ghazzar, N; Hartmann, O; Hattner, R; Hoefnagel, CA; Jamadar, DA; Kim, E; Kloos, R; Leung, A; Lizotte, P; Lumbroso, J; Rufini, V; Shapiro, B; Shulkin, BL; Sisson, JC; Thein, A; Troncone, L | 1 |
Beck, D; Bischof Delaloye, A; Gudinchet, F; Lebtahi, N; Nenadov-Beck, M | 1 |
Bergeron, C; Combaret, V; Frappaz, D; Giammarile, F; Guibaud, L; Louis, D; Ranchere-Vince, D; Schell, M; Souillet, G; Thiesse, P | 1 |
Hino, M; Kawabe, J; Kobashi, T; Koda, M; Ochi, H; Okamura, T; Yamada, R | 1 |
Ablin, A; DeSantes, K; Hasegawa, B; Hattner, RS; Huberty, J; Matthay, KK; Price, D; Reynolds, CP; Seeger, RC; Weinberg, VK | 1 |
Fabre, M; Gauthier, F; Gruner, M; Hartmann, O; Helardot, PG; Josset, P; Larroquet, M; Lumbroso, J; Martelli, H; Michon, J; Paraf, F; Patte, C; Ricard, M; Tabone, MD; Terrier-Lacombe, MJ; Wioland, M | 1 |
Brans, B; Dhooge, C; Dierckx, RA; Laureys, G; Potter, CR; Schelfhout, V; Simons, M; Wiele, CV | 1 |
Britton, KE | 1 |
Plowman, PN | 1 |
Meller, S | 1 |
Shapiro, B; Shulkin, BL | 1 |
DeSantes, K; Goldberg, SS; Hasegawa, BH; Hattner, R; Huberty, JP; Matthay, KK; Price, D; Reynolds, CP; Seeger, RC | 1 |
McEwan, AJ; McQuarrie, SA; Miller, GG; Roa, WH; Tse, J; Wiebe, LI; Wu, J | 1 |
Mastrangelo, R; Mastrangelo, S; Tornesello, A | 1 |
Cunningham, SH; Mairs, RJ; Vaidyanathan, G; Welsh, PC; Wheldon, TE; Zalutsky, MR | 1 |
Cruz Martínez, O; Ferrer Ferrán, J; Iriondo Sanz, M; Manzanares, R; Moreno Hernando, J; Ortega Rodríguez, J | 1 |
Bader, P; Bares, R; Beck, J; Handgretinger, R; Hero, B; Jürgens, H; Klingebiel, T; Lang, P; Niethammer, D; Rath, B | 1 |
Maeda, T; Okitsu, S; Okuyama, C; Sugihara, H; Ushijima, Y | 1 |
Benoit, Y; De Moerloose, B; Dhooge, C; Dierckx, RA; Laureys, G; Philippé, J; Speleman, F; Van de Wiele, C | 1 |
Heyman, S; Tepmongkol, S | 1 |
Kinuya, S; Tonami, N; Yokoyama, K | 1 |
Alonso Rodríguez, M; Castejón Sánchez, I; Escribano Arias, M; Freile García, I; Mariño Pfeiffer, E; Martínez García, G; Ortiz Berrocal, J; Peiró Valgañón, V; Ramos Sanz, J | 1 |
Hugosson, C; Jacobsson, B; Jorulf, H; Kofide, A; McDonald, P; Nyman, R; Rifai, A | 1 |
Ben Arush, MW; Ben Itzhak, O; El Hasid, R; Israel, O; Postovsky, S; Yossilevski, G | 1 |
Shulkin, BL; Sisson, JC | 1 |
Blanco, JA; Casasa, JM; Castellví, A; Fraile, M; Isnard, RM; Javier, G; López, P; Prats, J; Riba, J | 1 |
Burak, Z; Cetingül, N; Kantar, M; Moretti, JL; Ozkiliç, H; Yüksel, DA | 1 |
Nishimura, T; Okuyama, C; Sugihara, H; Ushijima, Y; Watanabe, K | 1 |
Bellagamba, O; Bertolazzi, L; Cabria, M; Claudiani, F; De Bernardi, B; Garaventa, A; Lanino, E; Lo Piccolo, MS; Milanaccio, C; Scopinaro, G; Villavecchia, GP | 1 |
Mairs, RJ | 1 |
Lasorella, A; Mastrangelo, R; Meco, D; Riccardi, A; Riccardi, R; Servidei, T | 1 |
Hara, Y; Hayashi, A; Horiike, S; Ishii, K; Kubo, A; Kusakabe, K; Masaki, H; Murata, H | 1 |
Hoefnagel, CA | 1 |
Bonneu, A; Chauvot, P; Edeline, V; Frappaz, D; Giammarile, F; Gomez, F; Siles, S; Wioland, M | 1 |
Kinouchi, H; Mizoi, K; Sasajima, T; Tomura, N; Watarai, J | 1 |
Ariga, M; Hara, A; Kume, N; Matsunaga, N; Motoyama, K; Ogasawara, N; Suga, K | 1 |
Bembo, V; Mastrangelo, R; Mastrangelo, S; Rufini, V; Tornesello, A | 1 |
Buitenhuis, CK; Hoefnagel, CA; Rutgers, M; Smets, LA; Voûte, PA | 1 |
Biasotti, S; Cabria, M; De Bernardi, B; Garaventa, A; Nantron, M; Villavecchia, GP | 1 |
Kirsch, CM; Samnick, S; Sax, B | 1 |
Chou, S; Yanchar, NL | 1 |
Lehm, JP; Melbourne, GJ | 1 |
Ambros, IM; Ambros, PF; Bihl, H; Borgström, P; Jacobsson, H; Kogner, P; Martinsson, T; Schilling, FH; Schwarz, K; Treuner, J | 1 |
Acha, T; Cañete, A; Castel, V; Contra, T; Cruz, O; Galarón, P; García-Miguel, P; Melero, C; Molina, J; Navajas, A | 1 |
Buitenhuis, CK; Hoefnagel, CA; Rutgers, M; Smets, LA; van der Valk, MA; Voûte, PA | 1 |
Diociaiuti, L; Mastrangelo, R; Mastrangelo, S; Pession, A; Prete, A; Rufini, V; Tornesello, A; Troncone, L | 1 |
Da Silva, AJ; Hasegawa, BH; Hawkins, RA; Huberty, JP; Matthay, KK; Price, DC; Tang, HR | 1 |
Dosel, P; Hermanská, E; Kavan, P; Krízová, H; Sázel, M; Stanková, J | 1 |
Berthold, F; Simon, T; Voth, E | 1 |
Amstutz, H; Buitenhuis, CK; Carrel, F; de Kraker, J; Hoefnagel, CA; Meli, M; Novak-Hofer, I; Rutgers, M; Schubiger, PA; Smets, LA | 1 |
Nakamura, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
Bertolazzi, C; Cabria, M; Dallorso, S; De Bernardi, B; Garaventa, A; Miano, M; Piccolo, MS; Pizzitola, MR; Villavecchia, GP | 1 |
Brans, B; De Ridder, L; Dierckx, RA; Monsieurs, MA; Thierens, HM; Vral, A | 1 |
Kikkawa, M; Nakamura, T; Nishimura, T; Okuyama, C; Ushuima, Y | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeung, HW | 1 |
Berthold, F; Gahr, M; Hero, B; Hunneman, DH | 1 |
Cole, M; Ellershaw, C; Lewis, IJ; Pearson, AD; Pinkerton, CR; Tweddle, DA | 1 |
Bello Arques, P; Cañete, A; Castell, V; Fernández, JM; González Cabezas, P; Hervás Benito, I; Mateo Navarro, A; Monfort, JA; Pérez Pastor, JL; Rivas Sánchez, A; Ruiz Rodríguez, JC; Saura Quiles, A | 1 |
Campus, R; Carlini, C; Claudiani, F; Conte, M; Granata, C; Rizzo, A | 1 |
Chan, GC; Lee, AC; Leung, YL; Ling, SC; Luk, CW; Shing, MM | 1 |
Garaventa, A | 1 |
Borgström, P; Dahllöf, G; Jacobsson, H; Kogner, P; Lundell, G | 1 |
Glidden, DV; Hasegawa, B; Hawkins, RA; Huberty, J; Matthay, KK; Panina, C; Price, D; Tang, HR; Veatch, J | 1 |
Bais, E; Boot, H; de Kraker, J; Hoefnagel, CA; Taal, B; Valdés Olmos, RA; Vote, PA | 1 |
Franke, WG; Grüning, T; Kropp, J | 1 |
Mitjavila, M | 1 |
Pritchard, J | 1 |
Bares, R; Geiger, L; Haase, B; Handgretinger, R; Müller-Schauenburg, W; Niethammer, D; Reuland, P; Thelen, MH | 1 |
Braun, T; Ferrara, JL; Hubers, D; Hutchinson, RJ; Levine, JE; Matthay, KK; Shapiro, B; Shulkin, BL; Sisson, JC; Spalding, S; Yanik, GA | 1 |
de Kraker, J; Swart, JF; van der Lely, N | 1 |
Kikkawa, M; Kubota, T; Nakamura, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
Carbone, R; Cornaglia-Ferraris, P; Montaldo, PG; Ponzoni, M | 1 |
Endo, K; Kaneko, M; Kubo, A; Kusakabe, K; Masaki, H; Nakajo, M; Sasaki, Y; Yamashita, M | 1 |
Babich, JW; Flower, MA; Lambrecht, RM; Ott, RJ; Tait, D | 1 |
Horne, T | 1 |
Dykes, TM; Greene, MK; Hattner, RS; Moraldo, TV; Parisi, MT; Sandler, ED | 1 |
Hutchinson, RJ; Shapiro, B; Shulkin, BL | 1 |
Ackery, DM; Fielding, SL; Flower, MA; Kemshead, J; Lashford, LS; Lewis, IJ | 1 |
Bourliere Najean, B; Cammilleri, S; Devred, P; Faure, F; Kaphan, G; Panuel, M; Siles, S | 1 |
Ackery, D; Fielding, SL; Flower, MA; Kemshead, JT; Lashford, LS; Lewis, IJ; Meller, S | 1 |
Barrett, A; Boyack, SM; Gaze, MN; Mairs, RJ; Wheldon, TE | 1 |
Feine, U; Klingebiel, T; Niethammer, D; Reuland, P | 1 |
Gaze, MN; Huxham, IM; Mairs, RJ; Workman, P | 1 |
Hattner, RS; Parisi, MT; Sandler, ED | 1 |
Carey, JE; Francis, IR; Hutchinson, RJ; Johnson, JW; Miser, JS; Normole, D; Shapiro, B; Shulkin, BL; Sisson, JC; Zasadny, K | 1 |
Hattner, RS; Huberty, JP; Matthay, KK; Parisi, MT | 1 |
Englaro, EE; Gelfand, MJ; Harris, RE; Smith, HS | 1 |
Carter, R; Corbett, R; Fairley, N; Husband, J; McElwain, T; Meller, S; Moyes, J; Olliff, J; Pinkerton, R; Treleaven, J | 1 |
Loesberg, C; Romijn, JC; Smets, LA; Van Rooji, H | 1 |
Casalaro, A; Cornaglia-Ferraris, P; Lanciotti, M; Montaldo, PG; Ponzoni, M | 1 |
Beierwaltes, WH | 5 |
Barrett, A; Gaze, MN; Mairs, RJ | 1 |
Burch, L; Cheung, NK; Finn, R; Kushner, BH; Laquaglia, M; Larson, SM; Yeh, SD | 1 |
Ackery, D; Fielding, SL; Flower, MA; Kemshead, JT; Lashford, LS; Lewis, I | 1 |
Hancock, JP; Kemshead, JT; Lashford, LS | 1 |
Arrighini, A; Bertolazzi, L; Bestagno, M; Claudiani, F; De Bernardi, B; Garaventa, A; Guerra, P; Lanino, E; Villavecchia, GP | 1 |
de Kraku, J; Hoefnagel, CA; Smets, L; Voûte, PA | 1 |
Angerson, W; Babich, JW; Gaze, MN; Mairs, RJ; McSharry, C; Murray, T; Reid, R | 1 |
Barrett, A; Gaze, MN; Huxham, IM; Mairs, RJ | 1 |
Berthold, F; Feine, U; Fischer, M; Klingebiel, T; Maul, FD; Niethammer, D; Schwabe, D; Treuner, J; Waters, W; Wehinger, H | 1 |
Babich, JW; Barrett, A; Meller, ST; Moyes, JS; O'Donoghue, JA; Wheldon, TE | 2 |
Buttenhuis, C; Janssen, M; Ritzen, K; Rutgers, M; Smets, LA | 1 |
Bihl, H; Heinze, HG; Sautter-Bihl, ML | 1 |
Bakker, DJ; de Kraker, J; Hoefnagel, CA; Valdes Olmos, R; van de Kleij, AJ; Voûte, PA | 1 |
Ackery, D; Fielding, S; Flower, MA; Kemshead, J; Lashford, LS; Lewis, IJ | 1 |
Gubbels, AA; Hoefnagel, CA; Rutgers, M; Smets, LA; Voûte, PA | 1 |
Corbett, R; Flower, M; Fullbrook, A; Meller, S | 1 |
Bruchelt, G; Kaulich, T; Klingebiel, T; Niethammer, D; Smykowski, H; Treuner, J | 1 |
Angerson, WJ; Babich, JW; Mairs, RJ; Murray, T | 1 |
Bruchelt, G; Gupta, D; Handgretinger, R; Kaleva, N; Klingebiel, T; Niethammer, D; Treuner, J; Wollmann, H | 1 |
Clarke, J; Kemshead, JT; Lashford, LS | 1 |
Grapin, C; Gruner, M; Larroquet, M; Wioland, M | 1 |
Benz-Bohm, G; Gross-Fengels, W; Linden, A; Widemann, B | 1 |
Berthold, F; Linden, A; Sieverts, H; Waters, W | 1 |
Fig, LM; Gross, MD; Khafagi, F; Shapiro, B | 1 |
Ben-Harush, M; Bettman, L; Frenkel, A; Front, D; Iosilevsky, G; Ish-Shalom, S; Israel, O; Kolodny, GM; Steiner, M | 1 |
Murashima, S; Nakagawa, T; Okuda, Y; Sakurai, M; Takeda, K | 1 |
Lumbroso, J; Schlumberger, M | 1 |
Dicks-Mireaux, C; Gordon, I; Gutman, A; Morony, S; Peters, AM; Pritchard, J | 1 |
Danza, FM; Lasorella, A; Mastrangelo, R; Montemaggi, P; Rufini, V; Troncone, L | 1 |
Chatal, JF; Coornaert, S; Fritsch, P; Guerreau, D; Masse, R; Metivier, H; Nolibe, D; Saccavini, JC; Thedrez, P | 1 |
Delree, M; Desprechins, B; Ferster, A; Ham, HR; Jacobs, A; Jonckheer, MH; Mertens, J; Otten, J; Piepsz, A | 1 |
Janssen, M; Loesberg, C; Metwally, E; Smets, LA | 1 |
Delrée, M; Desprechins, B; Ham, HR; Jacobs, A; Jonckheer, MH; Mertens, J; Otten, J; Piepsz, A | 1 |
Hutchinson, RJ; Mallette, SA; Mudgett, EE; Normolle, D; Shapiro, B; Singer, DA; Sisson, JC; Wahl, RL; Wieland, DM; Zasadny, KR | 1 |
Bruchelt, G; Buck, J; Dopfer, R; Feine, U; Girgert, R; Kaiser, W; Klingebiel, T; Meinke, J; Müller-Schauenburg, W; Treuner, J | 1 |
Adolph, J; Kimmig, B | 1 |
Krikke, AP; van der Jagt, EJ | 1 |
Melino, G | 1 |
Dopfer, R; Ehninger, G; Feine, U; Keller, KD; Klingebiel, T; Niethammer, D; Treuner, J | 1 |
Kelly, JU | 1 |
Agertoft, L; Andreassen, M; Berglund, G; Kreuger, A; Nygård, R; Salmi, TT; Schmiegelow, K; Simes, MA; Storm-Mathisen, I; Wiebe, T | 1 |
Ebner, F; Fueger, GF; Hausegger, KA; Urban, C | 1 |
Brendel, AJ; Drouillard, J; Guyot, M; Jeandot, R; Lambert, B | 1 |
Köhl, U; Rohrbach, E; Schwabe, D | 1 |
Huiskamp, R; Janssen, M; Loesberg, C; Metwally, EA; Smets, LA | 1 |
Agrawal, M; Babich, JW; Carter, R; McElwain, TJ; Meller, ST; Moyes, JS | 1 |
Kriegel, H; Laubenbacher, C; Möllenstädt, S; Pabst, HW; Senekowitsch, R | 1 |
Ebener, U; Kornhuber, B; Paffenholz, V | 1 |
Friedman, A; Garty, I; Kedar, A; Sandler, MP | 1 |
Lasorella, A; Mastrangelo, R; Montemaggi, P; Riccardi, R; Rufini, V; Troncone, L | 2 |
Iwashita, S; Nakabeppu, Y; Nakajo, M; Sakata, H; Shimabukuro, K; Shinohara, S; Taguchi, M; Tanoue, T; Yonekura, R | 1 |
Feine, U | 1 |
Bruchhausen, A; Eissner, D; Hahn, K | 1 |
Bomanji, J; Britton, KE; Conry, BG; Reznek, RH | 1 |
Hirayu, H; Izumi, M; Kakezono, F; Kiriyama, T; Kubo, I; Morita, S; Nagayama, Y; Ohtakara, S; Yamashita, S; Yokoyama, N | 1 |
Arnold, RW; Chan, R; Scott, J; Warshawski, RS | 1 |
Dicks-Mireaux, C; Gordon, I; Lashford, L; Pritchard, J | 1 |
Ackery, D; McEwan, AJ; Wyeth, P | 1 |
Verbruggen, RF | 1 |
Aubert, B; Coornaert, S; Hartmann, O; Lemerle, M; Lumbroso, JD; Merlin, L; Parmentier, C; Ricard, M; Schlumberger, M | 1 |
Ferster, A; Maurus, R; Otten, J; Schots, R | 1 |
de Kraker, J; Hoefnagel, CA; Marcuse, HR; Voûte, PA | 3 |
Shapiro, B; Shen, SW; Shulkin, BL; Sisson, JC | 1 |
Clarke, J; Gordon, I; Kemshead, JT; Lashford, LS; Pritchard, J | 1 |
Aprile, C; Burgio, GR; Carena, M; Miceli, A; Nespoli, L; Saponaro, R | 1 |
Erttmann, R; Helmke, K; Müller-Gärtner, HW | 2 |
Carey, JE; Hutchinson, RJ; Johnson, JW; Mallette, SA; Shapiro, B; Sisson, JC; Wieland, DM | 1 |
D'Angio, GJ; Evans, AE; Heyman, S | 1 |
Geatti, O; Hutchinson, R; Shapiro, B; Shulkin, B; Sisson, JC | 1 |
Darte, L; Tennvall, J | 1 |
Bayle, C; Caillaud, JM; Coornaert, S; Couanet, D; Guermazi, F; Hartmann, O; Leclère, JG; Lemerle, J; Lumbroso, JD; Rabarison, Y | 1 |
Bouvier, JF; Brunat Mentigny, M; Chauvot, P; Ducrettet, F; Lahneche, BE; Maïassi, N; Philip, T | 1 |
Gross, MD; Shapiro, B | 1 |
Feine, U; Klingebiel, T; Müller-Schauenburg, W; Treuner, J | 1 |
Bruchelt, G; Feine, U; Klingebiel, T; Niethammer, D; Treuner, J | 1 |
Gongora, G; Neuenschwander, S; Nguyen-Tan, T; Ollivier, L; Toubeau, M; Zucker, JM | 1 |
Benua, RS; Helson, L; Yeh, SD | 1 |
Babich, J; Evans, K; Fielding, S; Gordon, I; Kemshead, JT; Lashford, LS; Mellors, S; Moyes, J; Ott, R | 1 |
de Kraker, J; Hoefnagel, CA; Voûte, PA | 1 |
Coornaert, S; Guermazi, F; Hartmann, O; Lemerle, J; Lumbroso, J; Parmentier, C; Rabarison, Y | 1 |
Bruchelt, G; Buck, J; Girgert, R; Niethammer, D; Treuner, J; Wolburg, H | 1 |
Furudate, M; Ito, K; Kato, H; Nakata, K; Tsukamoto, E | 1 |
Franke, WG; Henke, E; Krautz, RM; Rönisch, P | 1 |
Baum, RP; Busse, E; Hör, G; Kornhuber, B | 1 |
Dopfer, R; Feine, U; Gerein, V; Happ, J; Klingebiel, T; Kornhuber, B; Maul, F; Niethammer, D; Schwabe, D; Treuner, J | 1 |
de Kraker, J; Hoefnagel, CA; Majoor, M; Voûte, PA | 1 |
Kimura, M; Odano, I; Sakai, K; Takeda, M | 1 |
Edeling, CJ; Frederiksen, PB; Jeppesen, P; Kamper, J | 2 |
Antolini, M; Caputo, V; Castello, MA; Clerico, A; De Nardo, D; Mango, L; Melino, G; Taucci, M | 1 |
Caballero, O; Castel, V; Esquembre, C; Ferris, J; Verdeguer, A | 2 |
Baum, RP; Gerein, V; Happ, J; Hör, G; Kropp-von Rabenau, H; Manegold, K; Maul, F; Nitz, C; Sahm, S; Schwabe, D | 1 |
Deveaux, M; Marchandise, X; Mazingue, F; Millot, F; Venel, H; Verney, F; Ythier, H | 1 |
Hibi, S; Imashuku, S; Miyazaki, T; Todo, S | 1 |
Mauritzen, K; Nielsen, C; Schmiegelow, K; Yssing, M | 1 |
Nakajo, M; Shinohara, S | 1 |
Coakham, HB; Jones, DH; Kemshead, JT; Lashford, LS | 1 |
Mastrangelo, R | 1 |
de Kraker, J; Evans, AE; Green, A; Hayes, A; Hoefnagel, CA; Voûte, PA | 1 |
Fischer, M; Kraus, C; Ritter, J; Schröter, W; Wehinger, H | 1 |
Bestagno, M; Calculli, G; Colombo, L; Guerra, P; Puricelli, GP | 1 |
Aubert, B; Coonaert, S; De Lumley, L; Hartmann, O; Lemerle, J; Lumbroso, J; Merline, L; Olive, D; Ricard, M; Schlumberger, M | 1 |
Sanguineti, M | 1 |
Cottino, F; Favero, A; Grazia, G; Madon, E; Mussa, GC; Silvestro, L | 1 |
Deckart, H; Dörffel, W; Reuter, G; Selle, B; Weiss, ML; Wit, J | 1 |
Ehninger, G; Feine, U; Klingebiel, T; Kumbier, I; Schuler, U; Treuner, J; Waller, HD | 1 |
Hoshi, K; Kikuta, A; Midorikawa, S; Mizukoshi, H; Togawa, T | 1 |
Hadley, GP; Rabe, E | 1 |
Hosain, F; Jain, N; Kolstad, K; Leutzinger, EE; Spencer, RP; Spitznagle, LA | 1 |
Casteels-Van Daele, M; Coolens, JL; De Roo, M; Raes, M; Van de Casseye, W | 1 |
Habuchi, Y; Higa, T; Hino, M; Ikekubo, K; Ito, H; Jeong, S; Saiki, Y; Tsutsui, T; Yamaguchi, H; Yamaoka, K | 1 |
Aprils, C; Burgio, GR; Miceli, A; Nespoli, L | 1 |
Fujimori, K; Furudate, M; Itoh, K; Nakada, K; Saito, C; Tsukamoto, E | 1 |
Caballero Carpena, O; Castel Sánchez, V; Esquembre Menor, C; Ferris Tortajada, J; Verdeguer Miralles, A | 1 |
Habuchi, Y; Higa, T; Hino, M; Ikekubo, K; Ito, H; Jeong, S; Saiki, Y; Yamaguchi, H | 1 |
Büchler Frederiksen, P; Edeling, CJ; Jeppesen, P; Kamper, J | 1 |
Danza, FM; Lasorella, A; Maini, CL; Rufini, V; Troncone, L; Valenza, V | 1 |
Aboul-Enein, HY | 1 |
Odano, I; Sakai, K; Takeda, M | 1 |
Bruchelt, G; Buck, J; Girgert, R; Niethammer, D; Treuner, J | 1 |
Caballero, O; Castel, V; Esquembre, C; Ferris, J; Verdaguer, A | 1 |
Fischer, M; Galanski, M; Vetter, H; Winterberg, B | 1 |
Hoefnagel, CA; Maessen, HJ; Marcuse, HR; van der Steen, J | 1 |
Adolph, J; Brandeis, WE; Kimmig, B | 1 |
Treuner, J | 1 |
Munkner, T | 1 |
Beierwaltes, WH; Eyre, P; Geatti, O; Hutchinson, RJ; Mallette, S; Shapiro, B; Sisson, JC | 1 |
Brandeis, WE; Bubeck, B; Eisenhut, M; Georgi, P; Kimmig, B | 1 |
Haas, R; Kiess, W; Leisner, B | 1 |
Bomanji, J; Britton, KE; Dicks-Mireaux, C; Granowska, M; Hawkins, LA; Horne, T; Kemshead, JT; Kingston, J; Malpas, JS; Mather, S | 1 |
72 review(s) available for 3-iodobenzylguanidine and Neuroblastoma
Article | Year |
---|---|
The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Neuroendocrine Tumors; Neutropenia; Survival Rate; Treatment Outcome | 2022 |
The new international neuroblastoma response criteria.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Child; Humans; Iodine Radioisotopes; Neoplasm, Residual; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2019 |
MIBG in neuroblastoma diagnosis and treatment.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Child; Humans; Neuroblastoma; Norepinephrine; Radiopharmaceuticals | 2019 |
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Humans; Intestinal Neoplasms; Iodine Radioisotopes; Neoplasm Metastasis; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Rare Diseases; Stomach Neoplasms; Therapies, Investigational; Thyroid Neoplasms | 2020 |
Theranostics in Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Humans; Neuroblastoma; Precision Medicine; Radionuclide Imaging; Radiopharmaceuticals | 2021 |
[Radiological imaging of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Humans; Infant; Magnetic Resonance Imaging; Neuroblastoma; Positron-Emission Tomography; Radiography | 2021 |
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neuroblastoma; Observational Studies as Topic; Radiopharmaceuticals; Thyroid Diseases; Topotecan | 2017 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2017 |
Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2018 |
Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
Topics: 3-Iodobenzylguanidine; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Immunological; Clinical Trials as Topic; GTP Phosphohydrolases; Humans; Immunotherapy; Membrane Proteins; Molecular Targeted Therapy; Mutation; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neuroblastoma; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Radiotherapy; Risk Assessment; Sample Size; X-linked Nuclear Protein | 2018 |
MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Biological Availability; Child; Contraindications, Procedure; Drug Interactions; Humans; Neoplasm Staging; Neuroblastoma; Organ Sparing Treatments; Precision Medicine; Radioactive Tracers; Radionuclide Imaging; Radiopharmaceuticals; Theranostic Nanomedicine | 2018 |
Functional-metabolic imaging of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Medical Oncology; Neuroblastoma; Prognosis; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adult; Central Nervous System Neoplasms; Child; Dose Fractionation, Radiation; Female; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Pheochromocytoma; Radiometry; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2013 |
PET/CT imaging in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Contemporary approach to diagnosis and treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Bone and Bones; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Diagnostic Imaging; Disease Models, Animal; Female; Humans; Infant; Kinetics; Male; Medical Oncology; Mice; Neuroblastoma; Octreotide; Patient Safety; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Remission Induction; Sensitivity and Specificity; Tissue Distribution | 2013 |
131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biomarkers; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Humans; Medical Oncology; Neuroblastoma; Radiopharmaceuticals; Risk; Treatment Outcome | 2013 |
Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Medical Oncology; Neuroblastoma; Radiation-Sensitizing Agents; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Risk; Time Factors; Treatment Outcome | 2013 |
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Clinical Trials as Topic; Humans; Iodine Radioisotopes; Neuroblastoma; Radiotherapy Dosage; Research Design; Treatment Outcome | 2014 |
Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Contraindications; Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Pituitary Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Stomach Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2014 |
Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Prognosis; Radiopharmaceuticals | 2015 |
Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Combined Modality Therapy; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Iodine Radioisotopes; Neuroblastoma | 2015 |
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Neuroblastoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2015 |
¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications.
Topics: 3-Iodobenzylguanidine; Humans; Neoplasm Staging; Neuroblastoma; Treatment Outcome | 2016 |
Neuroblastoma: MIBG Imaging and New Tracers.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radionuclide Imaging | 2017 |
Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Combined Modality Therapy; Humans; Neuroblastoma; Radiopharmaceuticals; Radiotherapy Dosage | 2008 |
MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Follow-Up Studies; Humans; Neuroblastoma; Radionuclide Imaging; Risk | 2008 |
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Humans; Neuroblastoma; Radiation-Sensitizing Agents; Radiometry; Recurrence; Staining and Labeling | 2008 |
131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Animals; Combined Modality Therapy; Humans; Neuroblastoma; Neuroendocrine Tumors | 2010 |
Neuroblastoma: Therapeutic strategies for a clinical enigma.
Topics: 3-Iodobenzylguanidine; Adoptive Transfer; Angiogenesis Inhibitors; Antibodies, Monoclonal; Humans; Immunotherapy; Neoplasm Staging; Neuroblastoma | 2010 |
123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Data Interpretation, Statistical; Humans; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Research Design | 2010 |
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
Topics: 3-Iodobenzylguanidine; Advisory Committees; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Practice Guidelines as Topic; Radiation Injuries; Radiographic Image Enhancement; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed, Single-Photon | 2010 |
Modern nuclear medicine evaluation of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Therapeutic nuclear medicine in pediatric malignancy.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Child; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Thyroid Neoplasms | 2010 |
Concordance for neuroblastoma in monozygotic twins: case report and review of the literature.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Combined Modality Therapy; Comparative Genomic Hybridization; Cyclophosphamide; Diseases in Twins; Female; Fetofetal Transfusion; Humans; Infant; Iodine Radioisotopes; Liver Neoplasms; Male; Neuroblastoma; Placenta; Pregnancy; Radionuclide Imaging; Twins, Monozygotic; Ultrasonography; Vincristine | 2010 |
[Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Humans; Infant; Injections, Intravenous; Molecular Targeted Therapy; Neoplasm Proteins; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2011 |
Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience.
Topics: 3-Iodobenzylguanidine; Child; Combined Modality Therapy; Education; Humans; Neuroblastoma; Radiotherapy | 2011 |
Pediatrics: diagnosis of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Bone and Bones; Child; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Pediatrics; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Promising therapeutic targets in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal; Child; Child, Preschool; Combined Modality Therapy; Crizotinib; Gangliosides; Humans; Molecular Targeted Therapy; Neural Crest; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Precision Medicine; Pyrazoles; Pyridines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases | 2012 |
Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Mass Screening; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Treatment Outcome | 2003 |
A comparison of current neuroblastoma chemotherapeutics.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Humans; Neuroblastoma; Prognosis; Risk Factors; Stem Cell Transplantation | 2004 |
MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.
Topics: 3-Iodobenzylguanidine; Animals; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Infant, Newborn; Neuroblastoma; Octreotide; Patient Selection; Pentetic Acid; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Treatment Outcome | 2005 |
[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Combined Modality Therapy; DNA Damage; Enzyme Inhibitors; Humans; Neuroblastoma; Radiopharmaceuticals; Topoisomerase I Inhibitors; Topotecan | 2005 |
[Neuroendocrine tumours treated with mIBG and radiolabeled peptides].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Neuroendocrine; Combined Modality Therapy; Humans; Neuroblastoma; Paraganglioma; Peptides; Prognosis; Radiopharmaceuticals | 2006 |
Gene manipulation to enhance MIBG-targeted radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Animals; Drug Delivery Systems; Gene Targeting; Genetic Therapy; Humans; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Radiotherapy | 2005 |
Imaging of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; Catecholamines; Child; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Middle Aged; Neuroblastoma; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms | 2006 |
Targeted therapy in nuclear medicine--current status and future prospects.
Topics: 3-Iodobenzylguanidine; Female; Forecasting; Hematologic Neoplasms; Humans; Indium Radioisotopes; Male; Neoplasms; Neuroblastoma; Nuclear Medicine; Ovarian Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Survival Analysis; Thyroid Neoplasms; Treatment Outcome | 2007 |
Nuclear medicine imaging in pediatric oncology.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Child; Histiocytosis, Langerhans-Cell; Humans; Iodine Radioisotopes; Iodobenzenes; Leukemia; Lymphoma; Neoplasms; Neuroblastoma; Radionuclide Imaging; Thyroid Neoplasms | 1994 |
Meta-iodobenzylguanidine in children.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Contrast Media; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1993 |
Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Catecholamines; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1993 |
Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma | 1993 |
Radiolabelled mIBG in the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma | 1996 |
Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.
Topics: 3-Iodobenzylguanidine; Apudoma; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Neuroendocrine Tumors; Pheochromocytoma | 1996 |
The current status of targeted radiotherapy in clinical practice.
Topics: 3-Iodobenzylguanidine; Adult; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Leukemia; Lymphoma; Neoplasms; Neuroblastoma; Ovarian Neoplasms; Palliative Care; Polycythemia; Radioimmunotherapy; Radiotherapy; Thyroid Neoplasms | 1996 |
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Heart; Hormone Antagonists; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Sympathetic Nervous System; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Targeted radiotherapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Clinical Trials as Topic; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neuroblastoma; Radiation Tolerance | 1997 |
[Fetal cystic neuroblastoma: apropos 2 cases].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Female; Fetal Diseases; Humans; Iodine Radioisotopes; Neuroblastoma; Pregnancy; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Prenatal | 1998 |
131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Humans; Iodine Radioisotopes; Neuroblastoma; Radiopharmaceuticals; Treatment Outcome | 1999 |
[Internal radiation therapy for malignant neoplasm].
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Humans; Iodine Radioisotopes; Neuroblastoma; Pain; Palliative Care; Strontium Radioisotopes; Thyroid Neoplasms; Thyroidectomy | 1999 |
Nuclear medicine imaging of pheochromocytoma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Humans; Magnetic Resonance Imaging; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 1999 |
Nuclear medicine therapy of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neuroblastoma; Palliative Care; Radioimmunotherapy; Radiotherapy Dosage | 1999 |
[Therapeutic advances of nuclear medicine in oncology].
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma; Carcinoma, Medullary; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Iodine Radioisotopes; Liver Neoplasms; Lymphoma; Medical Oncology; Neoplasms; Neuroblastoma; Nuclear Medicine; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2001 |
[Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1992 |
Endocrine imaging: parathyroid, adrenal cortex and medulla, and other endocrine tumors. Part II.
Topics: 3-Iodobenzylguanidine; Adrenal Cortex; Adrenal Gland Diseases; Adrenal Medulla; Cushing Syndrome; Diagnostic Imaging; Endocrine System Diseases; Female; Humans; Hyperparathyroidism; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Octreotide; Ovarian Neoplasms; Parathyroid Glands; Radionuclide Imaging | 1991 |
Contributions of nuclear endocrinology to the diagnosis of adrenal tumors.
Topics: 3-Iodobenzylguanidine; Adosterol; Adrenal Gland Neoplasms; Adrenal Glands; Cushing Syndrome; Humans; Hyperaldosteronism; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1990 |
Radioiodinated iodobenzylguanidines for diagnosis and therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Carcinoid Tumor; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Tissue Distribution | 1986 |
Neuroblastoma today.
Topics: 3-Iodobenzylguanidine; Bone Marrow Transplantation; Child, Preschool; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Prognosis; Sympatholytics | 1988 |
Update on basic research and clinical experience with metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Medulla; Antibodies, Monoclonal; Calcium Channel Blockers; Follow-Up Studies; Humans; Hyperplasia; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Neuroblastoma; Pheochromocytoma; Tomography, X-Ray Computed | 1987 |
Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma | 1987 |
Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Ganglioneuroma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neuroblastoma; Norepinephrine; Rhabdomyosarcoma | 1987 |
Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1987 |
Horizons in radionuclide therapy: 1985 update.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antibodies, Neoplasm; Brachytherapy; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Neoplasms; Neuroblastoma; Pheochromocytoma; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Risk | 1985 |
67 trial(s) available for 3-iodobenzylguanidine and Neuroblastoma
Article | Year |
---|---|
[
Topics: 3-Iodobenzylguanidine; Child, Preschool; Humans; Neuroblastoma; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies | 2023 |
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neuroblastoma; Retrospective Studies; Transplantation, Autologous | 2023 |
Phase II study of
Topics: 3-Iodobenzylguanidine; Adolescent; Busulfan; Child; Child, Preschool; Chronic Disease; Humans; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Young Adult | 2023 |
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infant; Irinotecan; Male; Neoplasm Recurrence, Local; Neuroblastoma; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Vincristine; Vorinostat; Young Adult | 2021 |
Incorporation of high-dose
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Induction Chemotherapy; Infant; Melphalan; Neuroblastoma; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous; Young Adult | 2017 |
Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Male; Neuroblastoma; Prospective Studies; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2017 |
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
Topics: 3-Iodobenzylguanidine; Adolescent; Biological Transport; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Prognosis; Risk; Societies, Medical | 2018 |
Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site.
Topics: 3-Iodobenzylguanidine; Biological Transport; Child; Child, Preschool; Female; Humans; Image Processing, Computer-Assisted; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Multivariate Analysis; Neuroblastoma; Postoperative Period; Prognosis; Single Photon Emission Computed Tomography Computed Tomography | 2020 |
Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Female; France; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Metastasis; Neuroblastoma; Risk Factors; Topotecan | 2018 |
Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).
Topics: 3-Iodobenzylguanidine; Adolescent; Age Factors; Blood Pressure; Child; Child, Preschool; Female; Humans; Hypertension; Infant; Male; Neuroblastoma; Nifedipine; Radiopharmaceuticals; Retrospective Studies; Time Factors; Vasodilator Agents | 2013 |
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis.
Topics: 3-Iodobenzylguanidine; Anemia; Child; Child, Preschool; Female; Humans; Infant; Male; Nausea; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Vomiting | 2013 |
Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Iodine Radioisotopes; Irinotecan; Male; Maximum Tolerated Dose; Neuroblastoma; Radiotherapy Dosage; Vincristine; Young Adult | 2015 |
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Autografts; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Proton Therapy; Stem Cell Transplantation | 2015 |
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Acetylation; Adolescent; Adult; Aged; Child; Child, Preschool; Drug Monitoring; Female; Histones; Humans; Hydroxamic Acids; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiation-Sensitizing Agents; Treatment Outcome; Vorinostat; Young Adult | 2015 |
Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Autografts; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Prospective Studies; Risk Factors; Stem Cell Transplantation; Topotecan; Transplantation Conditioning | 2015 |
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Humans; Male; Neuroblastoma; Oxides; Paraganglioma; Pheochromocytoma; Radiation-Sensitizing Agents; Radiopharmaceuticals; Survival Analysis; Treatment Outcome | 2016 |
HIGH-DOSE 131I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.
Topics: 3-Iodobenzylguanidine; Adult; Caregivers; Child; Female; France; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radiation Exposure; Radiometry; Topoisomerase I Inhibitors; Topotecan | 2017 |
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age of Onset; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Hematologic Neoplasms; Humans; Infant; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Young Adult | 2016 |
Incorporation of high-dose
Topics: 3-Iodobenzylguanidine; Allografts; Autografts; Child; Child, Preschool; Disease-Free Survival; Female; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Male; Neuroblastoma; Pilot Projects; Receptors, KIR; Survival Rate | 2017 |
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Absorption; Adolescent; Child; Child, Preschool; Female; Humans; Liver; Male; Models, Biological; Neuroblastoma; Radiation Dosage; Radiometry | 2008 |
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Combined Modality Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Infusions, Intravenous; Male; Maximum Tolerated Dose; Neuroblastoma; Stem Cell Transplantation; Survival Analysis | 2009 |
(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Male; Middle Aged; Neuroblastoma; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Young Adult | 2009 |
Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Body Burden; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Whole-Body Counting; Young Adult | 2009 |
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2011 |
Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Brain Neoplasms; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Treatment Outcome | 2011 |
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adolescent; Antineoplastic Agents; Capsules; Child; Child, Preschool; Disease-Free Survival; Female; Fenretinide; Humans; Infant; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Irinotecan; Male; Maximum Tolerated Dose; Neuroblastoma; Prognosis; Tissue Distribution; Vincristine; Young Adult | 2012 |
Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Female; Homovanillic Acid; Humans; Infant; Japan; Male; Mass Screening; Neuroblastoma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vanilmandelic Acid; Whole-Body Counting | 2003 |
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Transplantation, Autologous | 2004 |
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Remission Induction; Treatment Outcome | 2004 |
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neuroblastoma; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2006 |
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iodine Radioisotopes; Kaplan-Meier Estimate; Logistic Models; Lymph Node Excision; Neoplasm Staging; Neuroblastoma; Radiation Injuries; Radiopharmaceuticals; Time Factors; Treatment Failure; Treatment Outcome; United States | 2007 |
Dosimetry for fractionated (131)I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Radiometry; Time Factors | 2007 |
The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Humans; Infant; Neoplasm Recurrence, Local; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Stem Cell Transplantation; Treatment Outcome | 2008 |
Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Humans; Hyperbaric Oxygenation; Infant; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radiation Tolerance; Survival Rate | 1995 |
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Thrombocytopenia; Treatment Outcome | 1995 |
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Child; Child, Preschool; Female; Gangliosides; Hemolysis; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Neuroblastoma; Radionuclide Imaging | 1995 |
131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Biopsy; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging; Survival Rate; Thoracic Neoplasms; Transplantation, Autologous | 1994 |
[Detection of neural crest tumors by 123I-MIBG scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1994 |
Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neural Crest; Neuroblastoma; Pheochromocytoma; Sensitivity and Specificity; Sympatholytics; Tomography, Emission-Computed, Single-Photon | 1994 |
Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Survival Analysis | 1994 |
Survival of patients with neuroblastoma treated with 125-I MIBG.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Platelet Count; Remission Induction; Survival Rate; Treatment Outcome | 1996 |
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Contrast Media; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Tomography, Emission-Computed | 1996 |
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Female; Follow-Up Studies; Humans; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed | 1997 |
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Humans; Infant; Iodine Radioisotopes; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Transplantation, Autologous | 1998 |
Intraoperative localization of neuroblastoma in children with 123I- or 125I-radiolabeled metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Child, Preschool; Female; Fibrosis; Gamma Cameras; Humans; Infant; Iodine Radioisotopes; Lymphatic Metastasis; Male; Monitoring, Intraoperative; Necrosis; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 1998 |
Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumour differentiation in vivo.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Count; Child; Child, Preschool; Chromosome Aberrations; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Male; Necrosis; Neoplasm Staging; Neuroblastoma; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Thoracic Neoplasms; Uterine Cervical Neoplasms | 1998 |
[123I-metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Neuroblastoma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon | 1998 |
Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein.
Topics: 3-Iodobenzylguanidine; Algorithms; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Flow Cytometry; Ganglioneuroma; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Proto-Oncogene Mas; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Whole-Body Counting | 1999 |
131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radiopharmaceuticals | 1999 |
[Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Catecholamines; Child; Child, Preschool; Echocardiography; Female; Heart; Humans; Infant; Male; Middle Aged; Myocardium; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Survival Rate | 2000 |
Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Neuroblastoma; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2001 |
Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Lung Diseases, Interstitial; Male; Neuroblastoma; Radiopharmaceuticals; Transplantation Conditioning; Treatment Outcome | 2001 |
Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Homovanillic Acid; Humans; Ifosfamide; Iodine Radioisotopes; Life Tables; Melphalan; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vanilmandelic Acid; Vincristine; Vindesine | 2001 |
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Diphosphonates; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Incidence; Infant; Iodine Radioisotopes; Kidney Diseases; Male; Neoplasm Staging; Nervous System Diseases; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Survival Analysis; Survival Rate; Technetium Compounds; Treatment Outcome; Vincristine | 2001 |
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Algorithms; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Neuroblastoma; Radiometry; Radiopharmaceuticals; Whole-Body Counting | 2001 |
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Transplantation, Autologous | 2002 |
Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2002 |
[The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Multiple Endocrine Neoplasia; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1992 |
Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Drug Resistance; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiotherapy Dosage; Treatment Outcome | 1992 |
Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiometry; Radiotherapy Dosage; Tissue Distribution | 1991 |
A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).
Topics: 3-Iodobenzylguanidine; Anemia; Antineoplastic Agents; Child, Preschool; Drug Evaluation; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Neutropenia; Radiation Injuries; Radionuclide Imaging; Thrombocytopenia | 1991 |
The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma | 1988 |
538 other study(ies) available for 3-iodobenzylguanidine and Neuroblastoma
Article | Year |
---|---|
Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.
Topics: Alkylation; Busulfan; Cell Survival; Guanidines; Humans; Molecular Structure; Neuroblastoma; Tumor Cells, Cultured | 2014 |
Design, synthesis, and biological evaluation of novel bifunctional thyrointegrin antagonists for neuroblastoma.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Molecular Structure; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thyroxine; Tumor Cells, Cultured | 2021 |
Anatomic patterns of relapse and progression following treatment with
Topics: 3-Iodobenzylguanidine; Disease Progression; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Retrospective Studies | 2022 |
The role of microscopic bone marrow examination and [
Topics: 3-Iodobenzylguanidine; Bone Marrow; Bone Marrow Examination; Bone Neoplasms; Humans; Iodine Radioisotopes; Neuroblastoma; Radionuclide Imaging | 2022 |
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Humans; Neuroblastoma; Radionuclide Imaging; Research Report | 2021 |
Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm, Residual; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous | 2022 |
Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries.
Topics: 3-Iodobenzylguanidine; Child; Hematopoietic Stem Cell Transplantation; Humans; Neuroblastoma; Radionuclide Imaging; Transplantation, Autologous | 2022 |
MIBG Uptake in a Gastric Gastrointestinal Stromal Tumor.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Gastrointestinal Stromal Tumors; Humans; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Stomach Neoplasms | 2022 |
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Humans; Iodine Radioisotopes; Neuroblastoma; Radionuclide Imaging | 2022 |
Thyroid function after diagnostic
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Neuroblastoma; Potassium Iodide; Thyroid Gland | 2022 |
Asphericity of tumor [
Topics: 3-Iodobenzylguanidine; Adult; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; N-Myc Proto-Oncogene Protein; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Alpha Particles; Animals; Astatine; Guanidines; Humans; Iodine Radioisotopes; Mice; Mice, Inbred NOD; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured | 2022 |
Repeated treatment with low dose of
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Neuroblastoma | 2022 |
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Child; Consensus; Humans; National Cancer Institute (U.S.); Neuroblastoma; Treatment Outcome; United States | 2022 |
Time to resolution of iodine-123 metaiodobenzylguanidine (
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Humans; Iodine Radioisotopes; Neuroblastoma; Radionuclide Imaging | 2023 |
[A Report on Health Resource Use of Internal Radiation Therapy with
Topics: 3-Iodobenzylguanidine; Brachytherapy; Health Resources; Humans; Neuroblastoma | 2023 |
Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Child, Preschool; Demyelinating Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Myelitis; Neuroblastoma; Transplantation, Autologous | 2023 |
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (
Topics: 3-Iodobenzylguanidine; Animals; Histone Deacetylase Inhibitors; Humans; Mice; Neuroblastoma; Neuroendocrine Tumors; Phosphatidylinositol 3-Kinases; Precision Medicine | 2023 |
Leptomeningeal Metastasis From Neuroblastoma Revealed by 123 I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Humans; Meningeal Carcinomatosis; Neuroblastoma; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2023 |
[131-I-meta-iodo-benzyl-guanidine therapy in childhood neuroblastoma.]
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Guanidines; Humans; Neoplasm Recurrence, Local; Neuroblastoma | 2023 |
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to
Topics: 3-Iodobenzylguanidine; Chronic Disease; Humans; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Vesicular Monoamine Transport Proteins | 2024 |
Is Overexpression of the Plasma Membrane Transporter (
Topics: 3-Iodobenzylguanidine; Equilibrative Nucleoside Transport Proteins; Humans; Iodine Radioisotopes; Membrane Transport Proteins; Neuroblastoma | 2023 |
Renal Metastasis From Neuroblastoma Shown on MIBG Imaging.
Topics: 3-Iodobenzylguanidine; Child; Female; Humans; Kidney Neoplasms; Neuroblastoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography | 2020 |
Mediastinal cystic lymphangioma in an infant:
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Humans; Infant; Iodine Radioisotopes; Lymphangioma, Cystic; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Neuroblastoma; Radionuclide Imaging | 2020 |
Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Recurrence; Retrospective Studies | 2020 |
Restoration of I-131 whole body image using a Wiener filter.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Cohort Studies; Female; Humans; Image Processing, Computer-Assisted; Infant; Infant, Newborn; Male; Neuroblastoma; Radiation Dosage; Radionuclide Imaging; Retrospective Studies; Signal-To-Noise Ratio; Thyroid Gland; Whole Body Imaging | 2020 |
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Cancer Vaccines; Child; Combined Modality Therapy; Humans; Iodine Radioisotopes; Japan; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome; Vaccination; WT1 Proteins | 2020 |
[Thyroid dysfunction due to 131I-metaiodobenzylguanidine in patients with neuroblastoma].
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Cross-Sectional Studies; Female; Humans; Hypothyroidism; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroid Diseases | 2020 |
68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Whole Body Imaging | 2020 |
A model for in situ plan of care for a critically unstable pediatric patient following I-131 MIBG infusion.
Topics: 3-Iodobenzylguanidine; Child; Critical Care; Critical Illness; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Michigan; Models, Statistical; Neuroblastoma; Patient-Centered Care; Prognosis; Radiation Exposure; Radiopharmaceuticals; Radiotherapy Dosage | 2020 |
Absorbed dose simulation of meta-
Topics: 3-Iodobenzylguanidine; Guanidine; Half-Life; Humans; Monte Carlo Method; Neuroblastoma; Radiation Dosage; Tissue Distribution | 2021 |
Topics: 3-Iodobenzylguanidine; Animals; Benzamides; Cell Line, Tumor; Endocytosis; Female; Fluorobenzenes; Guanidines; Humans; Mice, Nude; Morpholines; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Pyrimidines; Radiopharmaceuticals; Tissue Distribution; TOR Serine-Threonine Kinases | 2020 |
123I-metaiodobenzylguanidine (MIBG)-positive testicular mass in a neuroblastoma.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Radiopharmaceuticals; Testis | 2020 |
Editorial for "Comparison between diffusion weighted MRI and
Topics: 3-Iodobenzylguanidine; Diffusion Magnetic Resonance Imaging; Humans; Neuroblastoma | 2021 |
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine; Magnetic Resonance Imaging; Neuroblastoma; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2021 |
The Association between Tumour Markers and Meta-iodobenzylguanidine Scans in South African Children with High-risk Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Child; Humans; Neuroblastoma; Radionuclide Imaging; Reproducibility of Results | 2021 |
MIBG Uptake in Pancreas as a Normal Variant.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Humans; Neuroblastoma; Pancreas; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon | 2022 |
Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Correlation of Data; Female; Humans; Image-Guided Biopsy; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Whole Genome Sequencing; Young Adult | 2021 |
Selective use of Peptide Receptor Radionuclide Therapy following comparative imaging of Ga-68 DOTATATE PET/CT against I-131 MIBG scintigraphy in a small Asian cohort of Adult Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Receptors, Somatostatin | 2021 |
131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Drug Resistance, Neoplasm; Humans; Infant; Iodine Radioisotopes; Neoplasm Staging; Neuroblastoma; Prognosis | 2021 |
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome.
Topics: 3-Iodobenzylguanidine; Guanidine; Humans; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies | 2021 |
Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Feasibility Studies; Female; Humans; Induction Chemotherapy; Infant; Infant, Newborn; Male; Myeloablative Agonists; Neoplasm Staging; Neuroblastoma; Pilot Projects; Retrospective Studies; Stem Cell Transplantation; Surgical Procedures, Operative; Thoracic Neoplasms; Time Factors; Transplantation, Autologous | 2017 |
RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with
Topics: 3-Iodobenzylguanidine; Humans; Incidence; Iodine Radioisotopes; Neoplasms, Second Primary; Neuroblastoma; Radiopharmaceuticals; Risk Factors | 2017 |
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Cohort Studies; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate | 2017 |
Evaluation of the utility of
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Cohort Studies; Contrast Media; Cross-Sectional Studies; Follow-Up Studies; Humans; Iodine Radioisotopes; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2017 |
Unusual Presentation of Relapse in Neuroblastoma: Pancreatic Metastases Detected by 123I-MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Marrow; Humans; Male; Neuroblastoma; Pancreatic Neoplasms; Recurrence; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
Neuroblastoma Presenting as Non-MIBG-Avid Widespread Soft Tissue Metastases Without Bone Involvement Revealed by FDG PET/CT Imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2017 |
Improved outcome of
Topics: 3-Iodobenzylguanidine; Animals; Cell Line, Tumor; Disease Models, Animal; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Neuroblastoma; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Biomarkers; Child; Child, Preschool; Female; Humans; Male; Membrane Proteins; Neuroblastoma; Neutropenia; Pilot Projects; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2017 |
Persistent positive metaiodobenzylguanidine scans after autologous peripheral blood stem cell transplantation may indicate maturation of stage 4 neuroblastoma.
Topics: 3-Iodobenzylguanidine; Autografts; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Radiopharmaceuticals; Survival Rate | 2017 |
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.
Topics: 3-Iodobenzylguanidine; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Infant; Male; Molecular Targeted Therapy; Neuroblastoma; Octreotide; Organometallic Compounds | 2018 |
SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biological Transport; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Neuroblastoma; Recurrence; Retrospective Studies; Risk; Single Photon Emission Computed Tomography Computed Tomography | 2018 |
I-123-MIBG scintigraphy in patients with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Time Factors; Whole Body Imaging; Young Adult | 2018 |
Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal/extraadrenal primary identified on imaging.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Contrast Media; Developmental Disabilities; Diagnosis, Differential; Female; Fingers; Humans; Infant, Newborn; Intellectual Disability; Liver Neoplasms; Magnetic Resonance Imaging; Microcephaly; Muscle Hypotonia; Myopia; Neoplasm Staging; Neuroblastoma; Obesity; Organometallic Compounds; Retinal Degeneration; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2018 |
Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Brain Neoplasms; Caregivers; Child; Child, Preschool; Female; Humans; Infant; Male; Medical Staff; Metabolic Clearance Rate; Neuroblastoma; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Safety | 2018 |
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Infant; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Young Adult | 2018 |
Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Disease Progression; Female; Humans; Immunohistochemistry; Male; Molecular Imaging; Molecular Targeted Therapy; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Prevalence; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence | 2019 |
Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma
Topics: 3-Iodobenzylguanidine; Adult; Child; Chromosome Aberrations; Humans; Neuroblastoma; Precision Medicine; Radiometry; Risk | 2019 |
Molecular Scaffolds as Double-Targeting Agents For the Diagnosis and Treatment of Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Mice, Inbred NOD; Mice, SCID; Models, Molecular; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Optical Imaging | 2019 |
Dosimetry-based high-activity therapy with
Topics: 3-Iodobenzylguanidine; Adolescent; Chemoradiotherapy; Child; Child, Preschool; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Progression-Free Survival; Radiometry; Recurrence; Remission Induction; Retrospective Studies; Risk; Topotecan; Treatment Outcome; Young Adult | 2019 |
Increased Gastric MIBG Activity as a Normal Variant.
Topics: 3-Iodobenzylguanidine; Adolescent; Biological Transport; Female; Gastric Mucosa; Humans; Neoplasm Metastasis; Neuroblastoma; Recurrence; Single Photon Emission Computed Tomography Computed Tomography; Stomach | 2019 |
Successful treatment of refractory metastatic neuroblastoma with panobinostat in combination with chemotherapy agents and iodine-131-meta-iodobenzylguanidine therapy.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; Female; Histone Deacetylase Inhibitors; Humans; Iodine Radioisotopes; Neoplasms, Second Primary; Neuroblastoma; Panobinostat; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2020 |
Novel Meta-iodobenzylguanidine-Based Copper Thiosemicarbazide-1-guanidinomethylbenzyl Anticancer Compounds Targeting Norepinephrine Transporter in Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Copper; Drug Delivery Systems; Guanidines; Humans; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Semicarbazides | 2019 |
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
Topics: 3-Iodobenzylguanidine; Antibodies; Child; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Research Report; Stem Cell Transplantation | 2013 |
Theranostic role of MIBG in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Humans; Medical Oncology; Neuroblastoma; Peptides; Positron-Emission Tomography; Radioisotopes; Tomography, X-Ray Computed | 2013 |
Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neoplasms, Unknown Primary; Neuroblastoma; Palliative Care; Retrospective Studies; Treatment Outcome | 2013 |
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Dihydroxyphenylalanine; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Disparities in uptake pattern of (123)I-MIBG, (18)F-FDG, and (99m)Tc-MDP within the same primary neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biological Transport; Child; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2014 |
131I-Metaiodobenzylguanidine conditioning regimen in children with neuroblastoma undergoing stem cell transplantation.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Marrow Transplantation; Child; Fatal Outcome; Female; Humans; Infant; Iodine Radioisotopes; Mucositis; Neuroblastoma; Stem Cell Transplantation; Transplantation Conditioning | 2013 |
The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Female; Head and Neck Neoplasms; Humans; Infant; Infant, Newborn; Male; Neuroblastoma; Pelvic Neoplasms; Radiopharmaceuticals | 2013 |
Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy.
Topics: 3-Iodobenzylguanidine; Adolescent; Caregivers; Child; Child, Preschool; Environmental Exposure; Feasibility Studies; Hospitals; Humans; Neuroblastoma; Nurses; Radiotherapy Dosage; Safety; Time Factors | 2013 |
Diagnostic and therapeutic use of MIBG in pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Potassium Iodide; Retrospective Studies; Thyroid Diseases; Thyroid Gland; Time | 2013 |
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Young Adult | 2013 |
Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Female; Humans; Male; Neuroblastoma; Radionuclide Imaging; Whole Body Imaging | 2013 |
Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Catecholamines; Child; Child, Preschool; Female; Heart; Humans; Male; Myocardium; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Female; Humans; Iodine Radioisotopes; Neuroblastoma; Primary Ovarian Insufficiency; Radiation Injuries; Spinal Cord Compression; Spinal Neoplasms | 2014 |
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
Topics: 3-Iodobenzylguanidine; Acetylation; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Metformin; Mitochondria; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Phenformin; Proto-Oncogene Proteins c-myc; Up-Regulation | 2014 |
Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Topics: 3-Iodobenzylguanidine; Animals; Cell Line, Tumor; Diagnostic Imaging; Fluorobenzenes; Guanidines; Humans; Immunoblotting; Immunohistochemistry; Mice; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2014 |
Isolated late CNS relapse in a young adult 10 years after initial treatment for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Bone Neoplasms; Brain Neoplasms; Female; Humans; Neuroblastoma; Recurrence; Time Factors; Young Adult | 2015 |
Application of nuclear medicine to achieve less invasive surgery for malignant solid tumors in children.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Feasibility Studies; Female; Humans; Male; Neuroblastoma; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2014 |
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Prognosis; Prospective Studies; Radionuclide Imaging; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Induction Chemotherapy; Infant; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies | 2014 |
Bone and lymph node metastases from neuroblastoma detected by (18)F-DOPA-PET/CT and confirmed by posttherapy (131)I-MIBG but negative on diagnostic (123)I-MIBG scan.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Dihydroxyphenylalanine; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Persistent intense MIBG activity in the liver caused by prior radiation.
Topics: 3-Iodobenzylguanidine; False Positive Reactions; Humans; Liver; Liver Neoplasms; Multimodal Imaging; Neuroblastoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Infant; Japan; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Second-Look Surgery; Survival Analysis; Treatment Outcome | 2014 |
Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dose-Response Relationship, Radiation; Female; Humans; Infant, Newborn; Iodine Radioisotopes; Monte Carlo Method; Neuroblastoma; Positron-Emission Tomography; Radiometry; Software; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Catheterization, Central Venous; Child; Combined Modality Therapy; Fatal Outcome; Female; Fever of Unknown Origin; Humans; Immunocompromised Host; Malassezia; Mycoses; Neuroblastoma; Splenic Diseases; Stem Cell Transplantation | 2014 |
Letter to the editor.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Occupational Exposure; Radiation Dosage; Radiation Exposure; Radiopharmaceuticals | 2015 |
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2014 |
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Multimodal Imaging; N-Myc Proto-Oncogene Protein; Neoplasm Metastasis; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Case report of PET/CT imaging of a patient with neuroblastoma using 18F-FPBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Biopsy; Bone Marrow; Bone Neoplasms; Guanidines; Humans; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tibia; Tomography, X-Ray Computed | 2014 |
Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Hypothyroidism; Infant; Male; Neoplasms, Radiation-Induced; Neuroblastoma; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms | 2015 |
Asymmetric thoracic metaiodobenzylguanidine (MIBG) activity due to prior radiation therapy.
Topics: 3-Iodobenzylguanidine; Child; Humans; Lung Neoplasms; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Thorax | 2015 |
Radioguided localization of neuroblastomas in laparoscopic surgery using (123)I- radiolabeled metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Laparoscopy; Monitoring, Intraoperative; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Surgery, Computer-Assisted | 2015 |
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
Topics: 3-Iodobenzylguanidine; Animals; Autoradiography; Fluorine Radioisotopes; Glioma; Guanidines; Iodobenzenes; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Whole-Body Pediatric Neuroblastoma Imaging: 123I-mIBG and Beyond.
Topics: 3-Iodobenzylguanidine; Child; Diffusion Magnetic Resonance Imaging; Humans; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2015 |
Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Marrow; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Neuroendocrine Tumors; Radionuclide Imaging; Radiotherapy Dosage; Whole-Body Counting; Young Adult | 2015 |
Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Biomarkers, Tumor; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Neuroblastoma; Prognosis; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Infant; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Immunohistochemistry; Male; Multimodal Imaging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Electrons; Female; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Topics: 3-Iodobenzylguanidine; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Infant; Neoplasm Metastasis; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Retrospective Studies; Treatment Outcome; Vesicular Monoamine Transport Proteins | 2016 |
Focally Increased MIBG Activity in the Muscle: Real Lesion or LOVENOX Injection Artifact?
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Anticoagulants; Artifacts; Enoxaparin; Female; Humans; Infant; Injections, Intramuscular; Liver Neoplasms; Muscles; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Neuroblastoma; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Statistics, Nonparametric; Whole-Body Irradiation; Young Adult | 2016 |
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Conscious Sedation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Infant; Infusions, Intravenous; Male; Neuroblastoma; Pyridazines; Radiopharmaceuticals | 2016 |
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Precision Medicine; Radiometry; Recurrence; Retrospective Studies; Treatment Failure; Young Adult | 2016 |
Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Biologically effective dose in fractionated molecular radiotherapy--application to treatment of neuroblastoma with (131)I-mIBG.
Topics: 3-Iodobenzylguanidine; Algorithms; Dose Fractionation, Radiation; Humans; Neuroblastoma; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness | 2016 |
Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Image Enhancement; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography | 2016 |
Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Neuroblastoma | 2016 |
Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
Topics: 3-Iodobenzylguanidine; Adrenal Cortex Hormones; Animals; Cell Line, Tumor; Drug Approval; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Male; Mice; Neuroblastoma; Octamer Transcription Factor-3; Prednisolone; Tissue Distribution | 2016 |
Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Neuroblastoma | 2016 |
Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; Humans; Male; Neuroblastoma; Radiometry; RNA, Messenger; Time Factors; Transcriptome; Whole-Body Irradiation; Young Adult | 2016 |
Diffusion-weighted Imaging Using Readout-segmented EPI Reveals Bony Metastases from Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Echo-Planar Imaging; Humans; Male; Neuroblastoma; Spine | 2016 |
Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Topics: 3-Iodobenzylguanidine; Dexmedetomidine; Humans; Hypnotics and Sedatives; Iodine Radioisotopes; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured | 2017 |
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Europe; Humans; Image Interpretation, Computer-Assisted; Internationality; Neuroblastoma; Observer Variation; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2017 |
Prolonged Isotretinoin in Ultra High-Risk Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Fatal Outcome; Female; Ganglioneuroblastoma; Hematopoietic Stem Cell Transplantation; Humans; Isotretinoin; Maintenance Chemotherapy; Male; Neuroblastoma; Remission Induction; Risk; Transplantation, Autologous | 2017 |
Primary Neuroblastoma Involving Spinal Canal.
Topics: 3-Iodobenzylguanidine; Female; Humans; Infant; Magnetic Resonance Imaging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Spinal Canal; Spinal Neoplasms | 2016 |
Objective comparison of lesion detectability in low and medium-energy collimator iodine-123 mIBG images using a channelized Hotelling observer.
Topics: 3-Iodobenzylguanidine; Child; Humans; Neuroblastoma; Phantoms, Imaging; Photons; Radionuclide Imaging; ROC Curve | 2017 |
Elevated MIBG Activity at the Site of Erythema of Unknown Etiology.
Topics: 3-Iodobenzylguanidine; Child; Erythema; Humans; Male; Neuroblastoma; Radiopharmaceuticals | 2017 |
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Female; Humans; Induction Chemotherapy; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk; Statistics, Nonparametric; Stem Cell Transplantation; Transplantation, Autologous; Whole-Body Irradiation | 2017 |
Estimated Internal and External Radiation Exposure of Caregivers of Patients With Pediatric Neuroblastoma Undergoing 131I Metaiodobenzylguanidine Therapy: A Prospective Pilot Study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Caregivers; Child; Child, Preschool; Female; Humans; Male; Mothers; Neuroblastoma; Pilot Projects; Prospective Studies; Radiation Exposure; Radiopharmaceuticals; Radiotherapy Dosage | 2017 |
Acrometastasis of Neuroblastoma to the Great Toe Revealed by MIBG Scan.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Hallux; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
Prominent Pulmonary Metastases Without Concurrent Osseous Involvement in Patients With High-Risk Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Female; Humans; Infant; Lung Neoplasms; Male; Neuroblastoma; Risk | 2017 |
Semi-quantitative scoring of skeletal metastases by
Topics: 3-Iodobenzylguanidine; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 2017 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Combined Chemotherapy Protocols; DNA Fragmentation; Glioma; Mice; Mice, Nude; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Topotecan; Treatment Outcome | 2008 |
[Role of 123-I-metaiodobenzylguanidine imaging as a component in the diagnosis and treatment of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Neuroblastoma; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
99mTc-HYNIC octreotide in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Humans; Male; Neuroblastoma; Octreotide; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Combined Modality Therapy; Endocrine Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2009 |
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone and Bones; Bone Marrow; Catecholamines; Disease-Free Survival; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2009 |
Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Ataxia; Child, Preschool; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Expanded availability of isotope boon to neuroblastoma diagnosis.
Topics: 3-Iodobenzylguanidine; Drug Approval; Half-Life; Humans; Iodine Radioisotopes; Neuroblastoma; Norepinephrine; Nortropanes; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; United States; United States Food and Drug Administration | 2009 |
Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Catecholamines; Cell Line, Tumor; Corticosterone; Desipramine; Dopamine; Gene Expression Regulation, Neoplastic; Humans; Ion Pumps; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Organic Cation Transport Proteins; Pheochromocytoma | 2009 |
[Neonatal neuroblastoma and prenatal diagnosis].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Diagnosis, Differential; Humans; Infant, Newborn; Magnetic Resonance Spectroscopy; Neoplasm Staging; Neuroblastoma; Prenatal Diagnosis; Radioisotope Renography; Radiopharmaceuticals; Treatment Outcome; Ultrasonography, Prenatal | 2009 |
Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Humans; Hypercalcemia; Isotretinoin; Male; Neoplasm Recurrence, Local; Neuroblastoma; Osteoblasts | 2009 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Cell Culture Techniques; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Mesenchymal Stem Cell Transplantation; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; T-Lymphocytes; Transplantation Chimera | 2009 |
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Dura Mater; Etoposide; Femur; Humans; Infant; Iodine Radioisotopes; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Remission Induction; Skin Neoplasms | 2009 |
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
False-positive MIBG scans with normal computed tomography imaging in patients with high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; False Positive Reactions; Female; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2009 |
Acute intravenous injection toxicity study of MIBG in mice.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Body Burden; Combined Modality Therapy; Dose-Response Relationship, Radiation; Injections, Intravenous; Iodine Radioisotopes; Lethal Dose 50; Mice; Mice, Inbred ICR; Neuroblastoma; Norepinephrine; Organ Size; Pheochromocytoma; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Dosage | 2010 |
123I-MIBG versus 18F-FDG: which is better, or which can be eliminated?
Topics: 3-Iodobenzylguanidine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Bone Marrow Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Liver Neoplasms; Male; Mediastinal Neoplasms; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Neoplasms; Spinal Neoplasms; Technetium Tc 99m Medronate | 2007 |
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Child; Humans; Neoplasm Metastasis; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radiometry; Radiotherapy Dosage; Time Factors; Whole-Body Counting | 2010 |
Residual lymph node metastasis in stage 4 neuroblastoma--advantage of radio-guided surgery?
Topics: 3-Iodobenzylguanidine; Child, Preschool; Disease-Free Survival; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Neuroblastoma; Surgery, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 2010 |
Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
Topics: 3-Iodobenzylguanidine; Animal Structures; Animals; Blood Pressure; Bone Marrow; Bradycardia; Dogs; Electrocardiography; Female; Heart; Heart Rate; Humans; Iodine Radioisotopes; Isotope Labeling; Male; Mice; Mice, Nude; Myocardium; Neuroblastoma; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
False-positive MIBG uptake in pneumonia in a patient with stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child, Preschool; False Positive Reactions; Female; Follow-Up Studies; Humans; Neoplasm Staging; Neuroblastoma; Pneumonia; Radionuclide Imaging; Tomography, X-Ray Computed | 2010 |
Hypothyroidism after treatment of metastatic neuroblastoma.
Topics: 3-Iodobenzylguanidine; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Male; Neuroblastoma; Radioimmunotherapy | 2010 |
[Neuroblastoma staging: discrepancies between ¹⁸F-FDG-PET and ¹²³I-MIBG].
Topics: 3-Iodobenzylguanidine; Child; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Child; Clinical Trials as Topic; Female; Humans; Iodine Radioisotopes; Liver; Liver Function Tests; Male; Neuroblastoma; Thyroid Gland; Young Adult | 2011 |
'Raccoon eyes' revisited.
Topics: 3-Iodobenzylguanidine; Animals; Humans; Infant; Male; Neoplasms, Multiple Primary; Neuroblastoma; Orbit; Orbital Neoplasms; Raccoons; Radionuclide Imaging; Radiopharmaceuticals | 2010 |
Neuroblastoma: management of a common childhood malignacy.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Combined Modality Therapy; Humans; Infant; Mutation; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2010 |
Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2011 |
Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Female; Humans; Male; Neuroblastoma; Radiopharmaceuticals; Recurrence; Survival Rate; Treatment Outcome | 2011 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
Topics: 3-Iodobenzylguanidine; Animals; Blotting, Western; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Tissue Distribution; Transplantation, Heterologous; Vorinostat | 2011 |
¹²³I-Metaiodobenzylguanidine 'superscan' in an adult patient with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Humans; Male; Neuroblastoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Biological Transport; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Infant; Male; Multimodal Imaging; Neoplasm Staging; Neuroblastoma; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Congenital agenesis of right parotid gland confounds MIBG scan interpretation in craniocervical neuroblastoma.
Topics: 3-Iodobenzylguanidine; Humans; Infant; Magnetic Resonance Imaging; Male; Nervous System Neoplasms; Neuroblastoma; Parotid Diseases; Parotid Gland; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Blood Pressure; Child; Child, Preschool; Female; Humans; Hypertension; Male; Neuroblastoma; Retrospective Studies | 2012 |
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification.
Topics: 3-Iodobenzylguanidine; Female; Humans; Male; Neuroblastoma; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography | 2012 |
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Topics: 3-Iodobenzylguanidine; Animals; Disease Models, Animal; Humans; Imaging, Three-Dimensional; Iodine Radioisotopes; Mice; Mice, Nude; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Positron-Emission Tomography; Radiation Dosage; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2012 |
Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Carcinoma; Carcinoma, Papillary; Child; Female; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Thoracic Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography | 2012 |
New semi-quantitative 123I-MIBG estimation method compared with scoring system in follow-up of advanced neuroblastoma: utility of total MIBG retention ratio versus scoring method.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Case-Control Studies; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Reproducibility of Results; Research Design; Retrospective Studies; Treatment Outcome | 2012 |
Abnormal MIBG uptake in a neuroblastoma patient with right upper lobe atelectasis.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Humans; Incidental Findings; Infant; Male; Neuroblastoma; Pulmonary Atelectasis; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Combined Modality Therapy; DNA Breaks; Female; Flow Cytometry; Histones; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Radiopharmaceuticals; Topotecan; Tumor Stem Cell Assay | 2012 |
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Brain Neoplasms; Chemistry, Pharmaceutical; Child; Child, Preschool; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neuroblastoma; Quality of Life; Radiation Dosage; Radiometry; Radiopharmaceuticals; Software; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2012 |
I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Time Factors; Whole Body Imaging; Young Adult | 2012 |
Differentiated thyroid carcinoma after iodine-131 metaiodobenzylguanidine treatment for neuroblastoma: assessment of causality.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Humans; Male; Neuroblastoma; Thoracic Neoplasms; Thyroid Neoplasms; Ultrasonography | 2013 |
Complicated appearance of an abdominal mass in the I-131 MIBG and Tc-99m bone scintigraphy of a patient with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone and Bones; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Dosimetry study of [I-131] and [I-125]- meta-iodobenz guanidine in a simulating model for neuroblastoma metastasis.
Topics: 3-Iodobenzylguanidine; Algorithms; Computer Simulation; Iodine Radioisotopes; Models, Biological; Neoplasm Metastasis; Neuroblastoma; Radiometry | 2013 |
131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Male; Melphalan; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2013 |
I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Fatal Outcome; Female; Humans; Infant; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals | 2012 |
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Neuroblastoma; Outpatients; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Temozolomide | 2013 |
Response to teszler.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Humans; Male; Neuroblastoma; Thoracic Neoplasms; Thyroid Neoplasms; Ultrasonography | 2013 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
Minimizing nuclear medicine technologist radiation exposure during 131I-MIBG therapy.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Neuroblastoma; Nuclear Medicine; Occupational Exposure; Radiation Dosage; Radiation Protection; Radiopharmaceuticals; Technology, Radiologic | 2013 |
Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Disease-Free Survival; Female; Germany; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Staging; Neuroblastoma; Observer Variation; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
[Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2002 |
111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuroblastoma; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2002 |
Total-body and red marrow dose estimates.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Algorithms; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Neuroblastoma; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage | 2003 |
Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Hypothyroidism; Infant; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2003 |
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Catecholamines; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Risk | 2003 |
Absorbed dose ratios for repeated therapy of neuroblastoma with I-131 mIBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Neuroblastoma; Radiotherapy Dosage | 2003 |
Role of MR imaging and iodine 123 MIBG scintigraphy in staging of pediatric neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Local delivery of (131)I-MIBG to treat peritoneal neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Body Burden; Dose-Response Relationship, Radiation; Female; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Nude; Neuroblastoma; Organ Specificity; Peritoneal Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tissue Distribution; Treatment Outcome; Whole-Body Counting | 2003 |
Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neuroblastoma; Patient Care Planning; Peripheral Blood Stem Cell Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2003 |
Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Methimazole; Neuroblastoma; Potassium Iodide; Radiation-Protective Agents; Thyroid Diseases; Thyroid Function Tests; Thyroxine; Treatment Outcome | 2003 |
Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Gamma Cameras; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Mice, Transgenic; Neoplasm Transplantation; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Transplantation, Heterologous | 2003 |
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biopsy; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; DNA Primers; DNA, Complementary; Humans; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Polymerase Chain Reaction; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Symporters | 2003 |
Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Blood Platelets; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Male; Neoplasm Staging; Neuroblastoma; Pain; Palliative Care; Radiopharmaceuticals; Retrospective Studies | 2003 |
Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Chronology as Topic; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neuroblastoma; Radiation Dosage; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution | 2004 |
Meeting the nursing challenges in treating children with 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Clinical Trials, Phase II as Topic; Hospitals, Pediatric; Humans; Iodine Radioisotopes; Models, Nursing; Neuroblastoma; Nurse Clinicians; Nurse Practitioners; Nurse's Role; Oncology Nursing; Organizational Innovation; Palliative Care; Patient Care Planning; Patient Care Team; Pediatric Nursing; Philadelphia; Philosophy, Nursing; Practice Guidelines as Topic | 2004 |
Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma; Adrenal Gland Neoplasms; Adrenergic Uptake Inhibitors; Biopsy; Carcinoid Tumor; Chromogranins; Clomipramine; Gastrointestinal Neoplasms; GTP-Binding Protein alpha Subunits, Gs; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Neuroendocrine Tumors; Neuropeptides; Pancreatic Neoplasms; Pheochromocytoma; Radionuclide Imaging; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Tumor Cells, Cultured; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2004 |
123I-MIBG uptake in the neck and shoulders of a neuroblastoma patient: damage to sympathetic innervation blocks uptake in brown adipose tissue.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Child, Preschool; Female; Humans; Neck; Neuroblastoma; Radiopharmaceuticals; Shoulder; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2004 |
A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Cell Line, Tumor; Humans; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Neuroblastoma; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2004 |
Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Cell Line, Tumor; Humans; Iodobenzenes; Metabolic Clearance Rate; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Usefulness of asialoglycoprotein receptor imaging for the evaluation of liver metastasis of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Asialoglycoprotein Receptor; Brain Neoplasms; Humans; Infant, Newborn; Liver; Liver Neoplasms; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate | 2004 |
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anemia; Bone Marrow; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome | 2005 |
Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
Topics: 3-Iodobenzylguanidine; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Radiation; Hematopoietic Stem Cells; Humans; Neuroblastoma; Radiopharmaceuticals; Treatment Outcome | 2004 |
No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
Topics: 3-Iodobenzylguanidine; Cell Line, Tumor; Humans; Iodine Radioisotopes; Isotope Labeling; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Additional value of I-123 MIBG SPECT in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Pain; Child, Preschool; Fever of Unknown Origin; Humans; Hypoventilation; Lung Neoplasms; Male; Neuroblastoma; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Infant; Iodine Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Muscle, Skeletal; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2005 |
Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neuroblastoma; Radiation Dosage; Radiation-Sensitizing Agents; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Topotecan; Whole-Body Counting | 2005 |
Endocrine late effects from multi-modality treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Endocrine System Diseases; Female; Growth Disorders; Humans; Hypogonadism; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radiopharmaceuticals; Survivors; Thyroid Diseases; Thyrotropin | 2005 |
Neuroblastoma stage 4S with 123I-MIBG-positive bone marrow involvement.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Marrow Neoplasms; Female; Humans; Infant; Nervous System Neoplasms; Neuroblastoma; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Comet Assay; DNA Damage; DNA Fragmentation; DNA, Complementary; Glioma; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Time Factors; Topotecan; Transfection | 2005 |
Importance of recognizing differences between bone marrow and bone cortex.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Infant; Iodine Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Muscle, Skeletal; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Neuroblastoma; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results | 2006 |
Exploiting the MIBG-avidity of neuroblastoma for staging and treatment.
Topics: 3-Iodobenzylguanidine; Humans; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
I-123 MIBG scan of metastatic neuroblastoma mimicking a bone scan.
Topics: 3-Iodobenzylguanidine; Adult; Bone and Bones; Femur; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2006 |
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Neoplasm Staging; Neuroblastoma; Regression Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (acth).
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Child, Preschool; False Positive Reactions; Female; Hormones; Humans; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
[Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG].
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Metabolic Clearance Rate; Neuroblastoma; Tissue Distribution | 2006 |
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth?
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Ganglioglioma; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Liver; Liver Function Tests; Male; Neuroblastoma; Radionuclide Imaging; Retrospective Studies; Somatostatin | 2007 |
Iodine-131-metaiodobenzylguanidine therapy with reduced-intensity allogeneic stem cell transplantation in recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Camptothecin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Iodine Radioisotopes; Irinotecan; Neuroblastoma; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 2008 |
Paratesticular neuroblastoma: a case against metastatic disease?
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Follow-Up Studies; Humans; Infant; Male; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2007 |
[Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Agents; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Effects of anesthetic agents on cellular 123I-MIBG transport and in vivo 123I-MIBG biodistribution.
Topics: 3-Iodobenzylguanidine; Anesthetics; Animals; Cell Line, Tumor; Drug Interactions; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Neuroblastoma; Organ Specificity; Pheochromocytoma; Radiopharmaceuticals; Tissue Distribution | 2008 |
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy.
Topics: 3-Iodobenzylguanidine; Adolescent; Amylases; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Male; Neuroblastoma; Pheochromocytoma; Radiopharmaceuticals; Sialadenitis | 2008 |
Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Drug Evaluation; Feasibility Studies; Female; Humans; Infant; Isotretinoin; Male; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Radiopharmaceuticals; Transplantation, Autologous; Treatment Outcome | 2008 |
I-123 metaiodobenzylguanidine (MIBG) in sympathetic denervation and reinnervation of salivary glands in a child with cervical neuroblastoma.
Topics: 3-Iodobenzylguanidine; Head and Neck Neoplasms; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands | 2008 |
Role of radio-iodinated meta-iodo benzyl guanidine in assessment of children with neuroblastoma at NEMROCK.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Biopsy, Needle; Bone and Bones; Bone Marrow; Child; Child, Preschool; Egypt; Female; Heart; Humans; Infant; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Myocardium; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Sensitivity and Specificity | 2006 |
Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Neuroblastoma; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
[Procedure guidelines for MIBG-scintigraphy in children].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Hematologic Neoplasms; Humans; Neuroblastoma; Pheochromocytoma; Practice Guidelines as Topic; Tomography, Emission-Computed, Single-Photon | 2008 |
Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Neuroblastoma; Radionuclide Imaging | 1984 |
[Results of scintigraphic studies with 131I-meta-benzylguanidine in space-occupying lesions of neuroectodermal origin].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Catecholamines; Child, Preschool; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Metanephrine; Middle Aged; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Vanilmandelic Acid | 1984 |
[Scintigraphic diagnosis of neuroblastoma and pheochromocytoma with 131I-meta-iodobenzylguanidine in pediatrics].
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pancreatic Neoplasms; Parietal Bone; Pheochromocytoma; Radionuclide Imaging | 1984 |
Localization of m-iodo(131I)benzylguanidine in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed | 1984 |
Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Sympatholytics | 1984 |
Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Carcinoid Tumor; Child; Child, Preschool; Creatinine; Humans; Iodine Radioisotopes; Iodobenzenes; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neuroblastoma; Pheochromocytoma | 1995 |
Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Base Sequence; Carrier Proteins; DNA Primers; Humans; Iodine Radioisotopes; Iodobenzenes; Molecular Sequence Data; Neuroblastoma; Norepinephrine; Polymerase Chain Reaction; Prognosis; RNA-Directed DNA Polymerase; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radiotherapy; Spheroids, Cellular; Tissue Distribution; Transplantation, Heterologous | 1995 |
Meta-iodobenzylguanidine (MIBG) inhibits malate and succinate driven mitochondrial ATP synthesis in the human neuroblastoma cell line SK-N-BE(2c).
Topics: 3-Iodobenzylguanidine; Adenosine Triphosphate; Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Humans; Iodobenzenes; Malates; Mitochondria; Neuroblastoma; Succinates; Succinic Acid; Tumor Cells, Cultured | 1995 |
Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Topics: 3-Iodobenzylguanidine; Biological Transport, Active; Carrier Proteins; Humans; Imipramine; Iodobenzenes; Neuroblastoma; Potassium; Temperature; Tumor Cells, Cultured | 1995 |
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
Topics: 3-Iodobenzylguanidine; Base Sequence; Biogenic Monoamines; Carrier Proteins; Gene Expression; Humans; Iodobenzenes; Molecular Sequence Data; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Polymerase Chain Reaction; Symporters; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 1995 |
A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Hematologic Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pilot Projects | 1995 |
New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma | 1995 |
The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Contrast Media; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 1995 |
Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Diphosphonates; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Ganglioneuroblastoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Organotechnetium Compounds; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Time Factors | 1995 |
Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Topics: 3-Iodobenzylguanidine; Child; Female; Gallium Radioisotopes; Hodgkin Disease; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphoma, Non-Hodgkin; Male; Neuroblastoma; Radionuclide Imaging; Rhabdomyosarcoma; Soft Tissue Neoplasms; Thallium Radioisotopes; Wilms Tumor | 1995 |
Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Models, Theoretical; Neuroblastoma; Radiation Dosage; Radiation Protection; Urinary Bladder | 1995 |
Rapid, reproducible pain relief with [131I]iodine-meta-iodobenzylguanidine in a boy with disseminated neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Head; Humans; Iodobenzenes; Male; Neuroblastoma; Pain Management; Radiography; Radiotherapy; Skull; Treatment Outcome | 1995 |
Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Feasibility Studies; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Melphalan; Neuroblastoma; Pilot Projects; Remission Induction; Whole-Body Irradiation | 1995 |
A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging; Remission Induction; Reproducibility of Results; Time Factors | 1995 |
I-131 MIBG scintigraphy of neuroectodermal tumors. Comparison between I-131 MIBG and In-111 DTPA-octreotide.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Child, Preschool; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Octreotide; Pentetic Acid; Pheochromocytoma; Radionuclide Imaging; Thoracic Neoplasms; Urinary Bladder Neoplasms | 1995 |
Interferon-gamma-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Biological Transport, Active; Biotechnology; Cell Differentiation; Cell Line; Half-Life; Humans; Interferon-gamma; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Recombinant Proteins; RNA, Messenger | 1993 |
No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Topics: 3-Iodobenzylguanidine; Animals; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
Locating neuroblastoma in the opsoclonus-myoclonus syndrome.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Contrast Media; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Myoclonus; Neuroblastoma; Ocular Motility Disorders; Radionuclide Imaging; Retrospective Studies; Syndrome | 1994 |
Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver; Lung; Neuroblastoma; Radiation Dosage; Radiometry; Urinary Bladder; Urodynamics | 1995 |
Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Cerebellum; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Paraganglioma; Radionuclide Imaging; Time Factors | 1994 |
Strong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radionuclide Imaging; Somatostatin; Transplantation, Heterologous | 1994 |
131I-MIBG scintigraphy in neural crest tumours.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma, Medullary; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neural Crest; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Neoplasms | 1994 |
(4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Glands; Animals; Contrast Media; Fluorine Radioisotopes; Humans; Iodobenzenes; Lipid Metabolism; Mice; Mice, Inbred BALB C; Myocardium; Neuroblastoma; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured | 1994 |
Synthesis of carrier-free 131I-meta-iodobenzyl-guanidine by novel routes to enhance therapeutic efficiency in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1994 |
Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; DNA, Neoplasm; Female; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Octreotide; Pentetic Acid; Ploidies; Prospective Studies; Radionuclide Imaging; Receptors, Somatostatin | 1994 |
Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Chromosome Deletion; Chromosomes, Human, Pair 1; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Octreotide; Pentetic Acid; Ploidies; Prognosis; Radionuclide Imaging; Receptors, Somatostatin; Survival Rate | 1994 |
International criteria for neuroblastoma diagnosis, staging, and response to treatment.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1994 |
[123I-MIBG scintigraphy in patients with neuroblastoma].
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1994 |
Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Female; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radiotherapy Dosage; Transplantation, Heterologous | 1994 |
Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Mediastinal Neoplasms; Neuroblastoma; Radionuclide Imaging | 1994 |
Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Desipramine; Female; Hot Temperature; Humans; Iodine Radioisotopes; Iodobenzenes; Kinetics; Neuroblastoma; Neurotransmitter Uptake Inhibitors; Ovarian Neoplasms; Temperature; Tumor Cells, Cultured | 1994 |
Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiotherapy Dosage; Thrombocytopenia | 1994 |
Primary hypothyroidism and 131I-MIBG therapy in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Humans; Hypothyroidism; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma | 1993 |
High-performance liquid chromatographic determination of m-iodobenzylguanidine in urine of cancer patients.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasms; Neuroblastoma; Spectrophotometry, Ultraviolet | 1993 |
Refining interpretation of MIBG scans in children.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Head and Neck Neoplasms; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Thoracic Neoplasms | 1994 |
Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Contrast Media; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1993 |
Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Brain Diseases; Eye Movements; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Myoclonus; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed | 1993 |
What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Prognosis; Radionuclide Imaging; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 1994 |
Neural crest tumors: I-123 MIBG imaging in children.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Child; Child, Preschool; Contrast Media; Female; Ganglioneuroblastoma; Humans; Infant; Infant, Newborn; Iodobenzenes; Male; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1994 |
Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.
Topics: 3-Iodobenzylguanidine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Thallium Radioisotopes; Thyroid Neoplasms | 1993 |
A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Biopsy, Needle; Bone Marrow; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Retrospective Studies | 1993 |
Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Ganglioneuroblastoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed; Ultrasonography | 1993 |
Characterization and uptake of radiolabelled meta-iodobenzylguanidine (MIBG) in a human neuroblastoma heterotransplant model in athymic rats.
Topics: 3-Iodobenzylguanidine; Animals; DNA-Binding Proteins; Homeodomain Proteins; Humans; Immunoblotting; Iodobenzenes; LIM-Homeodomain Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Nerve Tissue Proteins; Neuroblastoma; Phenotype; Radionuclide Imaging; Rats; Rats, Nude; Tissue Distribution; Transcription Factors | 1993 |
SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Topics: 3-Iodobenzylguanidine; Adrenal Medulla; Animals; Antineoplastic Agents; Contrast Media; Humans; Iodine Isotopes; Iodobenzenes; Mice; Mice, Nude; Microscopy; Neoplasm Transplantation; Neuroblastoma; Radiotherapy; Tissue Distribution | 1993 |
MIBG detection of hepatic neuroblastoma: correlation with CT, US and surgical findings.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Contrast Media; Diagnostic Errors; Female; Humans; Infant; Iodobenzenes; Liver; Liver Neoplasms; Male; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed; Ultrasonography | 1993 |
Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.
Topics: 3-Iodobenzylguanidine; Biological Transport; Cell Differentiation; Imipramine; In Vitro Techniques; Iodobenzenes; Kinetics; Neuroblastoma; Sodium; Temperature; Tumor Cells, Cultured | 1993 |
No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Animals; Contrast Media; Humans; In Vitro Techniques; Iodine Radioisotopes; Iodobenzenes; Isotope Labeling; Mice; Mice, Inbred BALB C; Neuroblastoma; Tumor Cells, Cultured | 1993 |
Lesion detection in neuroblastoma with iodine-131-MIBG.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1993 |
[Neuroblastoma: epidemiology and spontaneous remission. Significance for evaluation of screening studies].
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodobenzenes; Mass Screening; Neoplasm Regression, Spontaneous; Neuroblastoma; Radionuclide Imaging | 1993 |
Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Blood Platelets; Fluvoxamine; Humans; In Vitro Techniques; Iodobenzenes; Neuroblastoma; PC12 Cells; Rats; Serotonin; Sympatholytics; Tumor Cells, Cultured; Tyramine | 1993 |
Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Biological Transport; Cell Line; Cell Survival; Cerebellar Neoplasms; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Kinetics; Medulloblastoma; Neuroblastoma; Tumor Cells, Cultured | 1995 |
Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiotherapy Dosage | 1995 |
Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging | 1995 |
PET hydroxyephedrine imaging of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Carbon Radioisotopes; Child; Child, Preschool; Contrast Media; Deoxyglucose; Ephedrine; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Time Factors; Tomography, Emission-Computed | 1996 |
The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Contrast Media; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1993 |
Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Child, Preschool; Femoral Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1995 |
Raccoon eyes and the MIBG super scan: scintigraphic signs of neuroblastoma in a case of suspected child abuse.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child Abuse; Contrast Media; Diagnosis, Differential; Ecchymosis; Edema; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Orbital Diseases; Orbital Neoplasms; Radionuclide Imaging | 1995 |
The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Contrast Media; Female; Ganglioneuroblastoma; Ganglioneuroma; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 1996 |
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neuroblastoma; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed | 1996 |
Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Humans; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous | 1996 |
Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Follow-Up Studies; Humans; Hypothyroidism; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Prospective Studies; Radiotherapy; Thyroid Hormones | 1995 |
Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radiotherapy Dosage; Risk; Tomography, Emission-Computed, Single-Photon | 1996 |
Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Ganglioneuroblastoma; Ganglioneuroma; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Mediastinal Neoplasms; Neuroblastoma; Radionuclide Imaging; Somatostatin | 1996 |
Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biological Transport; Cell Differentiation; Half-Life; Humans; Interferon-gamma; Iodobenzenes; Neuroblastoma; RNA, Messenger; Tumor Cells, Cultured | 1996 |
Can preirradiation enhance tumor uptake of radiolabeled pharmaceuticals? Experimental data in a mouse neuroblastoma xenograft system.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Humans; Immunoconjugates; Immunoglobulin G; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radioimmunotherapy; Radiotherapy Dosage; Transplantation, Heterologous | 1996 |
Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon | 1996 |
Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Peripheral Nervous System Neoplasms; Radiotherapy, Adjuvant; Survival Rate; Sympathetic Nervous System | 1996 |
Could somatostatin scintigraphy be superior to MIBG scan in the staging of stage IVs neuroblastoma (Pepper's syndrome)?
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Marrow Neoplasms; Follow-Up Studies; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Somatostatin; Syndrome | 1996 |
Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Binding, Competitive; Humans; Iodine Radioisotopes; Iodobenzenes; Isotope Labeling; Male; Neuroblastoma; Piperazines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Doughnut appearance on I-131 MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1996 |
Peroperative (123)I-MIBG scan using a sterile probe for staging and resection of neuroblastoma in children.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Contrast Media; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Scintillation Counting; Signal Processing, Computer-Assisted; Sterilization | 1996 |
Radiation dosimetry for 131I-mIBG therapy of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Models, Theoretical; Neuroblastoma; Radiotherapy Dosage; Tissue Distribution | 1996 |
Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Disease Models, Animal; Female; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
Treatment of recurrent stage IV neuroblastomas with 131I-MIBG and HBO Six years follow-up.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Female; Follow-Up Studies; Humans; Hyperbaric Oxygenation; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Survival Rate; Time Factors | 1996 |
Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Topics: 3-Iodobenzylguanidine; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Spheroids, Cellular; Tumor Cells, Cultured | 1996 |
[Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Brain Neoplasms; Catecholamines; Child; Child, Preschool; Ferritins; Follow-Up Studies; Homovanillic Acid; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; L-Lactate Dehydrogenase; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Phosphopyruvate Hydratase; Radionuclide Imaging; Recurrence; Retrospective Studies; Time Factors; Vanillic Acid | 1996 |
Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Carcinoma, Medullary; Child; False Negative Reactions; False Positive Reactions; Follow-Up Studies; Heart; Humans; Hyperaldosteronism; Injections, Intravenous; Insulinoma; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardium; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Sensitivity and Specificity; Thyroid Neoplasms | 1995 |
Upper clavicular and cardiac meta-[123I]iodobenzylguanidine uptake in children.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adult; Bone Neoplasms; Child; Clavicle; Female; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver; Liver Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Myocardium; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 1995 |
Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Biopsy; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Diagnostic Imaging; False Negative Reactions; Female; Follow-Up Studies; Forecasting; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neoplasm Staging; Neuroblastoma; Pelvic Bones; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Sensitivity and Specificity; Spinal Neoplasms; Thoracic Neoplasms | 1995 |
[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Image Enhancement; Infant; Infant, Newborn; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Marrow Neoplasms; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Pheochromocytoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Survival Rate | 1995 |
Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone Neoplasms; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Italy; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Prognosis; Radiopharmaceuticals; Remission Induction; Survival Rate; Thoracic Neoplasms | 1995 |
[131I]MIBG as a first line treatment in advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance, Neoplasm; Feasibility Studies; Female; Humans; Infant; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm, Residual; Neuroblastoma; Postoperative Care; Radiopharmaceuticals; Remission Induction | 1995 |
The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction; Survival Rate | 1995 |
In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Glands; Adrenergic Uptake Inhibitors; Animals; Benzoates; Chromatography, High Pressure Liquid; Furans; Guanidines; Humans; Imipramine; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Myocardium; Neuroblastoma; Radiopharmaceuticals; Solvents; Tissue Distribution; Trimethylsilyl Compounds; Tumor Cells, Cultured | 1995 |
Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Hematologic Diseases; Hemorrhage; Humans; Infant; Infections; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction | 1995 |
Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Transplantation; Child; False Negative Reactions; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neoplasm, Residual; Neoplastic Cells, Circulating; Neuroblastoma; Polymerase Chain Reaction; Prognosis; Risk Factors; RNA-Directed DNA Polymerase; RNA, Messenger; Sensitivity and Specificity; Tyrosine 3-Monooxygenase; Vanilmandelic Acid | 1997 |
Intraoperative search for neuroblastoma by MIBG and radioguided surgery with the gamma detector.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Contrast Media; Feasibility Studies; Humans; Intraoperative Period; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Radionuclide Imaging; Radiosurgery; Reoperation | 1997 |
No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Topics: 3-Iodobenzylguanidine; Animals; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured | 1997 |
The mIBG super scan.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 1997 |
Menadione inhibits MIBG uptake in two neuroendocrine cell lines.
Topics: 3-Iodobenzylguanidine; Adrenergic Uptake Inhibitors; Animals; Antineoplastic Agents; Cytoplasmic Granules; Hemostatics; Humans; Imipramine; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; PC12 Cells; Rats; Reserpine; Vitamin K | 1997 |
A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carrier Proteins; Cell Count; Cisplatin; Humans; Iodobenzenes; Neoplasm Proteins; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Symporters; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1997 |
Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Topics: 3-Iodobenzylguanidine; Child; Contrast Media; False Negative Reactions; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Kidney Neoplasms; Male; Neuroblastoma; Radionuclide Imaging | 1997 |
[Recurrence of a stage IV neuroblastoma].
Topics: 3-Iodobenzylguanidine; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Contrast Media; Guanethidine; Humans; Iodine Radioisotopes; Iodobenzenes; Ligands; Neuroblastoma; Receptors, Adrenergic; Tumor Cells, Cultured | 1997 |
Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Carcinoid Tumor; Child; Child, Preschool; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Iodohippuric Acid; Kidney; Male; Middle Aged; Neuroblastoma; Paraganglioma; Pheochromocytoma | 1997 |
Neuroblastoma in adults and adolescents: an indolent course with poor survival.
Topics: 3-Iodobenzylguanidine; Actuarial Analysis; Adolescent; Adult; Age Factors; Catecholamines; Child; Child, Preschool; Contrast Media; Disease-Free Survival; Female; Gene Amplification; Genes, myc; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome | 1997 |
In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Cause of Death; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Ganglioneuroblastoma; Gene Amplification; Genes, myc; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
The place of mIBG imaging in the neuroblastoma diagnostic strategy.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Contrast Media; Diagnosis, Differential; Fractures, Stress; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Tibial Fractures | 1997 |
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Binding Sites; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured | 1997 |
MIBG causes oxidative stress and up-regulation of anti-oxidant enzymes in the human neuroblastoma cell line SK-N-BE(2c).
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antioxidants; Catalase; Cell Division; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Iodobenzenes; Lipid Peroxidation; Malondialdehyde; Neuroblastoma; Oxidative Stress; Tumor Cells, Cultured | 1997 |
Specificity of radioiodinated MIBG for neural crest tumors in childhood.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity | 1997 |
Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Neuroblastoma; Radionuclide Imaging | 1997 |
False positive MIBG scan.
Topics: 3-Iodobenzylguanidine; Aorta, Thoracic; Biopsy, Needle; Contrast Media; Diagnosis, Differential; False Positive Reactions; Ganglioneuroblastoma; Hemangioma, Capillary; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Mediastinal Neoplasms; Neuroblastoma; Radionuclide Imaging; Spinal Neoplasms; Tomography, X-Ray Computed | 1997 |
[A case of an adult neuroblastoma with bone-marrow metastases: 131I-MIBG scintigraphy in comparison with MRI].
Topics: 3-Iodobenzylguanidine; Adult; Bone Marrow Neoplasms; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms | 1997 |
Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Drug Interactions; False Negative Reactions; Humans; Kidney Neoplasms; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recurrence | 1997 |
Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Topics: 3-Iodobenzylguanidine; Antihypertensive Agents; Drug Interactions; False Negative Reactions; Humans; Kidney Neoplasms; Labetalol; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recurrence | 1997 |
Current concepts on the diagnostic use of MIBG in children.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Neuroblastoma; Pheochromocytoma; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals | 1998 |
Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Male; Neuroblastoma; Transplantation, Autologous | 1998 |
Targeted radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Humans; Microscopy, Confocal; Neuroblastoma; Radiopharmaceuticals; Radiotherapy; Spheroids, Cellular | 1998 |
Role of 131I-metaiodobenzylguanidine in the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Guidelines as Topic; Humans; Neuroblastoma; Pilot Projects; Prognosis; Radiopharmaceuticals | 1998 |
The MIBG super scan.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Humans; Iodine Radioisotopes; Neuroblastoma; Orbital Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 1998 |
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Combined Modality Therapy; Guanidines; Humans; Iodine Radioisotopes; Neuroblastoma; Sodium Iodide; Spheroids, Cellular; Tumor Cells, Cultured | 1998 |
Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Infant; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Risk Factors; Survival Analysis; Treatment Outcome | 1998 |
[Eight year history of neuroblastoma in an adult patient. Value of 123I-MIBG and 111In-DTPA-D-Phe-octreotide scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Bone Marrow; Bone Neoplasms; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Neuroblastoma; Octreotide; Pentetic Acid; Prognosis; Radionuclide Imaging; Receptors, Somatostatin | 1999 |
Imaging of abdominal neuroblastoma in children.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Biopsy; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Infant; Infant, Newborn; Lymph Nodes; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neuroblastoma; Reproducibility of Results; Retrospective Studies; Spinal Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 1999 |
Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Cell Differentiation; Child, Preschool; Ganglioneuroblastoma; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Prognosis; Radiopharmaceuticals | 1999 |
[Radio-guided surgery with MIBG in a case of abdominal neuroblastoma].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Catecholamines; Child, Preschool; Female; Follow-Up Studies; Humans; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Time Factors | 1999 |
[Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Biomarkers; Catecholamines; Child; Child, Preschool; Female; Homovanillic Acid; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Vanilmandelic Acid | 1999 |
Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Humans; Neuroblastoma; Radiopharmaceuticals | 1999 |
Influence of cisplatin and doxorubicin on 125I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Northern; Cisplatin; Doxorubicin; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radiopharmaceuticals; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Forecasting; Humans; Infant; Multicenter Studies as Topic; Neuroblastoma; Observer Variation; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Statistics as Topic; Treatment Outcome | 2000 |
High uptake of 123I-metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT.
Topics: 3-Iodobenzylguanidine; Aged; Humans; Male; Nasal Cavity; Neuroblastoma; Nose Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2000 |
Radioresistant sensitization of neuroblastoma by cisplatin?
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Child; Cisplatin; Drug Administration Schedule; Drug Synergism; Humans; Male; Neuroblastoma; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy, Adjuvant | 2000 |
Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
Topics: 3-Iodobenzylguanidine; Animals; Biotransformation; Dose Fractionation, Radiation; Drug Administration Schedule; Humans; Iodine Radioisotopes; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radioisotope Teletherapy; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Species Specificity; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |
False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child, Preschool; Disease-Free Survival; False Negative Reactions; Head and Neck Neoplasms; Humans; Infant; Iodine Radioisotopes; Magnetic Resonance Imaging; Neoplasm Staging; Neuroblastoma; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2000 |
[Positive presentation of a localized neuroblastoma in skeletal scintigraphy].
Topics: 3-Iodobenzylguanidine; Abdomen; Abdominal Neoplasms; Bone and Bones; Diphosphonates; Humans; Infant; Male; Neuroblastoma; Organotechnetium Compounds; Radiography, Abdominal; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Ultrasonography | 2000 |
Pitfalls in the interpretation of MIBG scans in cervical neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bias; Biopsy; Head and Neck Neoplasms; Horner Syndrome; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Quantifying the radiation exposure of nursing staff delivering hyperbaric oxygen therapy to grade IV neuroblastoma patients post 131I-MIBG therapy.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Child; Female; Humans; Hyperbaric Oxygenation; Neuroblastoma; Nurses; Occupational Exposure; Radiation Dosage | 2000 |
Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Infant; Infant, Newborn; Male; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Survival Rate | 2000 |
[(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Female; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neuroblastoma; PC12 Cells; Pheochromocytoma; Radiopharmaceuticals; Rats; Transplantation, Heterologous | 2000 |
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Neuroblastoma; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
[131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Male; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies | 2001 |
Asymmetric salivary gland 123I-meta-iodobenzylguanidine uptake in a patient with cervical neuroblastoma and Horner syndrome.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Horner Syndrome; Humans; Iodine Radioisotopes; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Spinal Cord Neoplasms | 2001 |
A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Antigens, Surface; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Infant; Leukocyte L1 Antigen Complex; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neural Cell Adhesion Molecules; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Transplantation, Heterologous; Tumor Cells, Cultured; Whole-Body Counting | 2001 |
Pseudoneuroblastoma demonstrated by I-123 MIBG SPECT.
Topics: 3-Iodobenzylguanidine; Female; Humans; Infant; Iodine Radioisotopes; Kidney Neoplasms; Neuroblastoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2001 |
Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Brain Neoplasms; Carcinoid Tumor; Child; Child, Preschool; Cobalt Radioisotopes; Female; Humans; Iodine Radioisotopes; Least-Squares Analysis; Male; Micronucleus Tests; Middle Aged; Neuroblastoma; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Statistics, Nonparametric | 2001 |
Thallium-201 scintigraphy of neuroblastoma: different results for primary tumors and skeletal lesions.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Neoplasms; Retrospective Studies; Thallium Radioisotopes | 2001 |
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Female; Ferritins; Ganglioneuroblastoma; Humans; Infant; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Neuroblastoma; Phosphopyruvate Hydratase; Predictive Value of Tests; Radionuclide Imaging; Retroperitoneal Neoplasms; Treatment Outcome | 2001 |
False positive MIBG scan due to accessory spleen.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Diagnosis, Differential; False Positive Reactions; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Spleen | 2001 |
Does a "false negative" MIBG scan predict a better outcome in neuroblastoma patients?
Topics: 3-Iodobenzylguanidine; Child; False Negative Reactions; Humans; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2001 |
Does a "false-negative" MIBG scan predict a better outcome in neuroblastoma patients?
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; False Negative Reactions; Female; Humans; Male; Neuroblastoma; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Erythema; Fatal Outcome; Female; Humans; Infant; Mouth Mucosa; Neuroblastoma; Stomatitis | 2001 |
Diffuse bone marrow infiltration of a neuroblastoma mimicking the findings of a bone marrow scan on I-123 MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Marrow; Bone Marrow Neoplasms; Child; Humans; Iodine Radioisotopes; Male; Neoplasm Invasiveness; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Meta-iodobenzylguanidine in neuroblastoma: from diagnosis to therapy.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Humans; Iodine Radioisotopes; Neuroblastoma; Radiopharmaceuticals | 2002 |
Re: Commentary by G.J. D'Angio to the article by S. Biasotti et al.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Humans; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
Topics: 3-Iodobenzylguanidine; Adolescent; Antibodies, Monoclonal; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Fluorescent Antibody Technique; Follow-Up Studies; Gangliosides; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Fusion Proteins; Soft Tissue Neoplasms; Technetium | 2001 |
High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Potassium Iodide; Premedication; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Diseases; Thyroid Gland; Thyrotropin; Thyroxine | 2002 |
Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Female; Humans; Infant; Neural Crest; Neuroblastoma; Paraneoplastic Syndromes, Nervous System; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Base Sequence; Biological Transport; Cell Differentiation; Gene Expression; Humans; In Vitro Techniques; Interferon-gamma; Iodobenzenes; Molecular Sequence Data; Neuroblastoma; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Receptors, Cell Surface; RNA, Messenger; Tumor Cells, Cultured | 1992 |
Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adult; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Pheochromocytoma; Radiometry; Radiotherapy Dosage; Tomography, Emission-Computed | 1992 |
Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Contrast Media; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Medronate | 1992 |
Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Marrow Diseases; Bone Neoplasms; Child; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Soft Tissue Neoplasms; Technetium Tc 99m Medronate | 1992 |
The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescription.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiometry; Radiotherapy Dosage | 1992 |
Value of MRI and MIBG-I123 scintigraphy in the diagnosis of spinal bone marrow involvement in neuroblastoma in children.
Topics: 3-Iodobenzylguanidine; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Neuroblastoma; Spinal Neoplasms | 1992 |
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
Topics: 3-Iodobenzylguanidine; Drug Screening Assays, Antitumor; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Tumor Cells, Cultured | 1992 |
[Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Follow-Up Studies; Germany; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1992 |
The use of parallel EEL spectral imaging and elemental mapping in the rapid assessment of anti-cancer drug localization.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Boron; Chemotherapy, Adjuvant; Drug Carriers; Electron Probe Microanalysis; Humans; Image Processing, Computer-Assisted; Iodobenzenes; Microscopy, Electron; Microspheres; Mitochondria; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured | 1992 |
Asymmetry of salivary gland I123 metaiodobenzylguanidine (MIBG) uptake in a patient with cervical neuroblastoma and Horner's syndrome--possible etiologic mechanisms.
Topics: 3-Iodobenzylguanidine; Female; Head and Neck Neoplasms; Horner Syndrome; Humans; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Salivary Glands | 1992 |
131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Salvage Therapy; Survival Analysis | 1992 |
Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Soft Tissue Neoplasms | 1992 |
I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Marrow Transplantation; Child; Child, Preschool; Contrast Media; Female; Humans; Infant; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Survival Rate | 1992 |
A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Marrow; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Neuroblastoma; Prospective Studies; Radionuclide Imaging | 1991 |
Mitochondrial effects of the guanidino group-containing cytostatic drugs, m-iodobenzylguanidine and methylglyoxal bis (guanylhydrazone).
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Humans; Intracellular Fluid; Iodobenzenes; Lymphoma, Non-Hodgkin; Mitochondria; Mitoguazone; Neuroblastoma; Polyamines; Tumor Cells, Cultured | 1991 |
Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biological Transport; Cell Line; Energy Metabolism; Humans; Iodobenzenes; Kinetics; Neuroblastoma; Ouabain; Sodium; Time Factors | 1991 |
The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biological Transport, Active; Desipramine; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Ouabain; Time Factors; Tumor Cells, Cultured | 1991 |
Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Biopsy; Child; Child, Preschool; Female; Gangliosides; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1991 |
Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Binding, Competitive; Biological Transport, Active; Cell Line; Desipramine; Dopamine; Dose-Response Relationship, Drug; Histamine; Humans; In Vitro Techniques; Iodobenzenes; Neuroblastoma; Norepinephrine; Serotonin; Tyramine | 1991 |
Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radiotherapy Dosage; Recurrence | 1991 |
Iodine-125-MIBG therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma | 1991 |
The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Autoradiography; Humans; Iodine Radioisotopes; Iodobenzenes; Nerve Growth Factors; Neuroblastoma; Tumor Cells, Cultured | 1991 |
Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biological Transport; Cell Line; Cell Nucleus; Cytoplasmic Granules; Humans; Iodine Radioisotopes; Iodobenzenes; Microscopy, Electron; Mitochondria; Neuroblastoma; Radiotherapy | 1991 |
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Germany; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Remission Induction; Survival Rate | 1991 |
Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Contrast Media; Half-Life; Humans; Iodine Radioisotopes; Iodobenzenes; Mathematics; Models, Biological; Neuroblastoma; Radiotherapy Dosage | 1991 |
Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Topics: 3-Iodobenzylguanidine; Acetylcholine; Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Autoradiography; Biological Transport; Cell Line; Exocytosis; Gamma Rays; Iodine Radioisotopes; Iodobenzenes; Kinetics; Neuroblastoma; Nifedipine; Norepinephrine; Pheochromocytoma; Rats; Verapamil | 1991 |
[The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Ganglioneuroma; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1991 |
Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1991 |
Specific uptake of 125-I-metaiodobenzylguanidine in human neuroblastoma cell lines is associated with the neuroblastic cell type.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biological Transport; Cell Differentiation; Cell Line; Clone Cells; Genetic Variation; Humans; Iodine Radioisotopes; Iodobenzenes; Kinetics; Neuroblastoma; Temperature | 1991 |
Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biological Transport; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Models, Statistical; Neuroblastoma; Probability; Prognosis | 1991 |
A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Cell Division; Cell Line; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous | 1991 |
123iodine meta-iodobenzylguanidine single photon emission computed tomography in the assessment of children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Heart; Heart Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Prospective Studies; Tomography, Emission-Computed, Single-Photon | 1991 |
Irradiation of human neuroblastoma cell lines by [131I-m]iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Analysis of Variance; Cell Division; Cell Line; Child; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Particle Accelerators | 1991 |
Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Biological Transport; Cell Line; Child; Drug Carriers; Humans; Immunoenzyme Techniques; Iodine Radioisotopes; Iodobenzenes; Models, Biological; Nerve Growth Factors; Neuroblastoma; Radionuclide Imaging | 1991 |
Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; beta-Endorphin; Child; Child, Preschool; Enkephalin, Methionine; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pain; Time Factors | 1991 |
Systemic administration of radionuclides in neuroblastoma as planned radiotherapeutic intervention.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Callitrichinae; Child; Contrast Media; Drug Carriers; Humans; Iodine Radioisotopes; Iodobenzenes; Kidney; Liver; Neuroblastoma; Tissue Distribution | 1990 |
[The value of isotopic intraoperative location of various neuroblastomas].
Topics: 3-Iodobenzylguanidine; Contrast Media; Humans; Intraoperative Care; Iodine Radioisotopes; Iodobenzenes; Neoplasm Invasiveness; Neuroblastoma; Radionuclide Imaging | 1990 |
[Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy].
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Marrow; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Neuroblastoma; Radionuclide Imaging | 1990 |
Immunoscintigraphic imaging of mIBG-negative metastases in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Child; Child, Preschool; False Negative Reactions; Fluorescent Antibody Technique; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Technetium | 1990 |
SPECT quantitation of iodine-131 concentration in phantoms and human tumors.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Carcinoid Tumor; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Structural; Neoplasms; Neuroblastoma; Pheochromocytoma; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon | 1990 |
[Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neuroblastoma; Radionuclide Imaging; Spinal Neoplasms | 1990 |
[Clinical applications of radio-labelled mIBG].
Topics: 3-Iodobenzylguanidine; Child, Preschool; Contrast Media; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1990 |
Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Topics: 3-Iodobenzylguanidine; Bone Marrow; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1990 |
The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1990 |
In vitro therapeutic targeting of neuroblastomas using 125I-labelled meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Autoradiography; Cell Line; Colony-Forming Units Assay; Contrast Media; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Time Factors; Tumor Cells, Cultured | 1990 |
Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Methods; Neuroblastoma; Paraganglioma; Radionuclide Imaging; Retinoblastoma; Thoracic Neoplasms | 1990 |
Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Cell Membrane Permeability; Deoxyglucose; Humans; Iodobenzenes; Neuroblastoma; Norepinephrine; Pheochromocytoma; Rats; Sympatholytics; Tumor Cells, Cultured | 1990 |
[I-MIBG scintigraphy in the diagnosis of neuroblastoma in children].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Mediastinal Neoplasms; Neuroblastoma; Pelvic Neoplasms; Radionuclide Imaging; Sympatholytics | 1990 |
Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Drug Evaluation; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Radiotherapy Dosage | 1990 |
Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Child, Preschool; Combined Modality Therapy; Evaluation Studies as Topic; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Palliative Care; Remission Induction | 1986 |
[Diagnosis and therapy of neuroectodermal tumors].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Pheochromocytoma; Tomography, X-Ray Computed | 1989 |
Adult neuroblastoma: a report of two cases.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Metastasis; Neuroblastoma; Retroperitoneal Neoplasms; Spinal Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Urography | 1989 |
[Intracellular uptake and accumulation of metaiodobenzylguanidine in neuroblastoma cells and small cell carcinoma of the lung].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Small Cell; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung Neoplasms; Male; Neuroblastoma; Radionuclide Imaging; Tumor Cells, Cultured | 1989 |
[131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Dose-Response Relationship, Radiation; Drug Evaluation; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Remission Induction; Time Factors | 1989 |
The use of an investigational radiopharmaceutical in neuroblastoma: a nursing perspective.
Topics: 3-Iodobenzylguanidine; Adult; Child; Clinical Protocols; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Patient Isolation; Potassium Iodide; Radiation Injuries; Sympatholytics; Thyroid Gland | 1989 |
Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Predictive Value of Tests; Radionuclide Imaging; Sympatholytics; Tomography, X-Ray Computed; Ultrasonography; Vanilmandelic Acid | 1989 |
[Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Ganglioneuroma; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1989 |
Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Pheochromocytoma; Retroperitoneal Neoplasms | 1989 |
Determination of m-iodobenzylguanidine in serum and urine by high-performance liquid chromatography.
Topics: 3-Iodobenzylguanidine; Chemical Phenomena; Chemistry; Child; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma | 1989 |
Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Topics: 3-Iodobenzylguanidine; Humans; Imipramine; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Norepinephrine; Reserpine; Time Factors; Tumor Cells, Cultured | 1989 |
Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms; Nervous System Neoplasms; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms; Sympatholytics | 1989 |
Therapeutic use of I-131-MIBG in nude mice hosting human neuroblastoma xenografts.
Topics: 3-Iodobenzylguanidine; Animals; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous | 1989 |
Uptake and release of iodine-labelled m-iodobenzylguanidine in a neuroblastoma cell culture system and its importance in neuroblastoma therapy.
Topics: 3-Iodobenzylguanidine; Doxorubicin; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Tumor Cells, Cultured | 1989 |
Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Child; Child, Preschool; Citrates; Citric Acid; Female; Gallium Radioisotopes; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1989 |
131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis.
Topics: 3-Iodobenzylguanidine; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
[Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
Topics: 3-Iodobenzylguanidine; Carboxylesterase; Carboxylic Ester Hydrolases; Child; Child, Preschool; Female; Homovanillic Acid; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; L-Lactate Dehydrogenase; Male; Neuroblastoma; Radionuclide Imaging | 1989 |
[Supplementary comments on the case report "Neuroblastoma IV S--a case report on hepatomegaly"].
Topics: 3-Iodobenzylguanidine; Hepatomegaly; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1988 |
[Neuroblastoma in Recklinghausen's disease].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Osteitis Fibrosa Cystica; Radionuclide Imaging; Whole-Body Counting; Whole-Body Irradiation | 1988 |
Imaging neural crest tumours with 123I-metaiodobenzylguanidine and X-ray computed tomography: a comparative study.
Topics: 3-Iodobenzylguanidine; Adult; Ganglioneuroma; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasms, Nerve Tissue; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 1988 |
[Clinical applications of 131I-meta iodobenzylguanidine (131I-MIBG) scintigraphy in Japan].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma; Humans; Iodobenzenes; Japan; Multiple Endocrine Neoplasia; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Experience with I-131-metaiodobenzylguanidine (MIBG): a retrospective study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Diagnostic Errors; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Middle Aged; Multiple Endocrine Neoplasia; Neurilemmoma; Neuroblastoma; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies | 1987 |
Specificity of iodobenzylguanidine scanning in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Sympatholytics | 1988 |
Fast high-yield labelling and quality control of [123I]- and [131I]MIBG.
Topics: 3-Iodobenzylguanidine; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Iodobenzenes; Isotope Labeling; Neuroblastoma; Quality Control; Radionuclide Imaging | 1987 |
Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Evaluation Studies as Topic; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neural Crest; Neuroblastoma; Radionuclide Imaging; Radiotherapy Dosage; Time Factors; Whole-Body Counting | 1987 |
Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Arm; Bone Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Leg; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Whole-Body Counting | 1987 |
A comparative study of the biodistribution of meta-iodobenzylguanidine (mIBG) and the monoclonal antibody UJ13A in patients and animal models.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Callitrichinae; Humans; Immunotherapy; Iodobenzenes; Neoplasms, Experimental; Neuroblastoma | 1988 |
The role of meta-iodo [131I]benzylguanidine (MIBG) in the diagnosis and follow-up of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Follow-Up Studies; Ganglioneuroma; Half-Life; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging | 1986 |
Meta-iodobenzylguanidine scintigraphy in neuroblastoma--a comparison with conventional X-ray and ultrasound.
Topics: 3-Iodobenzylguanidine; Child; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiography; Radionuclide Imaging; Ultrasonography | 1986 |
Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Leukopenia; Male; Neuroblastoma; Thrombocytopenia | 1988 |
I-131 metaiodobenzylguanidine: diagnostic use in neuroblastoma patients in relapse.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma | 1988 |
Gastrointestinal iodine-131-meta-iodobenzylguanidine activity.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Colon; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Tissue Distribution | 1988 |
Enhanced therapeutic tumour dose of 131I-MIBG by accelerated diuresis.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child, Preschool; Diuresis; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Time Factors | 1988 |
Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Male; Neuroblastoma; Tomography, Emission-Computed | 1988 |
Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neuroblastoma; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1988 |
Treatment of neuroblastoma with metaiodobenzylguanidine: results and side effects.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Marrow Transplantation; Bone Neoplasms; Catecholamines; Child; Child, Preschool; Female; Hematopoiesis; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pain | 1987 |
Local evaluation of abdominal neuroblastoma stage III and IV: use of US, CT, and 123 I-meta-iodobenzylguanidine (MIBG) scintigraphy.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Evaluation Studies as Topic; Female; Humans; Infant; Iodobenzenes; Male; Neuroblastoma; Tomography, X-Ray Computed; Ultrasonography | 1987 |
Correlation between iodine-131 MIBG imaging and biological markers in advanced neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Child; Child, Preschool; Dopamine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Phosphopyruvate Hydratase; Radionuclide Imaging; Vanilmandelic Acid | 1988 |
The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Chromatography, Thin Layer; Humans; Iodine Radioisotopes; Iodobenzenes; Liver; Neuroblastoma; Radionuclide Imaging; Radiotherapy Dosage; Sympatholytics; Time Factors; Tissue Distribution | 1988 |
131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Bone Marrow; Child; Child, Preschool; Drug Administration Schedule; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiotherapy Dosage | 1988 |
[Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Marrow; Bone Neoplasms; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lymphatic Metastasis; Neuroblastoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1988 |
Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
Topics: 3-Iodobenzylguanidine; Cell Line; Cell Survival; Dopamine; Drug Screening Assays, Antitumor; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Norepinephrine | 1988 |
[131I-MIBG scintigraphy of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1988 |
[Diagnostic localization of tumors of neuroectodermal origin using 131I-m-benzylguanidine].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1988 |
[Detection of the binding of 131I-meta-iodobenzylguanidine to structures of the plasma membranes of neuroblastoma cell lines].
Topics: 3-Iodobenzylguanidine; Animals; Cell Line; Cell Membrane; Humans; In Vitro Techniques; Iodine Radioisotopes; Iodobenzenes; Membrane Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Protein Binding; Transplantation, Heterologous | 1988 |
MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Male; Neuroblastoma | 1988 |
Side effects of treatment with I-131-meta-iodobenzylguanidine (I-131-MIBG) in neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Adult; Bone Marrow; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Female; Humans; Iodobenzenes; Male; Neuroblastoma; Thrombocytopenia | 1988 |
[Clinical significance of 131I meta-iodobenzylguanidine scintigraphy in neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1988 |
[131meta-Iodobenzyl guanidine scintigraphy in neuroblastoma].
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1987 |
[Diagnosis, monitoring and therapy of neuroblastoma using I-131 meta-iodobenzylguanidine].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pelvic Neoplasms; Radionuclide Imaging | 1986 |
[131I-MIBG-meta-iodobencylguanidine (131I-MIBG) in the study of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Male; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging | 1987 |
131-Metaiodobenzylguanedine therapy of neuroblastoma in childhood. One year of therapeutic experience.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Time Factors | 1987 |
[Results of scintigraphy with m-[123I]iodobenzylguanidine in neuroblastoma in children].
Topics: 3-Iodobenzylguanidine; Adolescent; Brain Neoplasms; Child; Child, Preschool; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging | 1987 |
131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Bone Marrow Diseases; Bone Neoplasms; Child, Preschool; Female; Gallium Radioisotopes; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Technetium | 1987 |
[131meta-iodobenzyl-guanidine scintigraphy of neuroblastomas].
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Male; Neuroblastoma; Prognosis; Radionuclide Imaging; Retrospective Studies | 1987 |
[131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1987 |
Diagnosis and therapy of neuroectodermally associated tumours using targeted radiation.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Brain Neoplasms; Humans; Iodobenzenes; Mice; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Radiography; Radioimmunoassay | 1987 |
International Society of Pediatric Oncology, Italian Society of Radiology and Nuclear Medicine, Italian Society of Biology and Nuclear Medicine, and Associazione Genitori Oncologia Pediatrica. IVth International Workshop in Pediatric Oncology: "The role o
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma | 1987 |
The treatment of neuroblastoma with 131I-MIBG.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma | 1987 |
Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Pheochromocytoma; Radiotherapy Dosage | 1987 |
Radionuclide therapy of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Child; Child, Preschool; Female; Humans; Iodobenzenes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neuroblastoma; Pheochromocytoma; Thyroid Neoplasms | 1987 |
Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: experience of the Münster/Kassel Group.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma | 1987 |
Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: the experience of an Italian Study Group.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Bone Neoplasms; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Neuroblastoma | 1987 |
Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patients.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Bone Marrow; Bone Neoplasms; Catecholamines; Child; Child, Preschool; Drug Evaluation; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Tissue Distribution | 1987 |
Considerations on 131I-metaiodobenzylguanidine therapy of six children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma | 1987 |
131I-metaiodobenzylguanidine treatment in neuroblastoma: report of two cases.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone Marrow; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neuroblastoma | 1987 |
Treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lymphatic Metastasis; Male; Neuroblastoma | 1987 |
[Experience with 131I-MIBG scintigraphy of children with neuroblastoma].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Neuroblastoma; Radionuclide Imaging; Thoracic Neoplasms | 1987 |
Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patients.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1987 |
Diagnosis and treatment of neuroblastoma using metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1987 |
[Scintigraphic localization of metastatic neuroblastoma using 131I-MIBG].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Child, Preschool; Female; Humans; Iodobenzenes; Neuroblastoma; Orbital Neoplasms; Radionuclide Imaging | 1986 |
Scanning with iodine-131 MIBG in children with solid tumors: an initial appraisal.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed; Urinary Bladder | 1986 |
Problem with mouse neuroblastoma (C 1300) as a model for iodine-131 MIBG uptake.
Topics: 3-Iodobenzylguanidine; Adrenal Glands; Animals; Disease Models, Animal; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Neuroblastoma; Radionuclide Imaging | 1986 |
Iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1986 |
The use of 131I-meta-iodobenzylguanidine in clinical diagnosis and staging of neuroectodermal tumors. Two case reports.
Topics: 3-Iodobenzylguanidine; Bone Marrow; Bone Neoplasms; Child, Preschool; Female; Ganglioneuroma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mediastinal Neoplasms; Neuroblastoma; Radionuclide Imaging; Tomography, X-Ray Computed | 1986 |
[Clinical usefulness of 131I-metaiodobenzylguanidine scintigraphy: experience in 6 cases].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Child; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1986 |
VMA-negative, MIBG scan-positive neuroblastoma in children.
Topics: 3-Iodobenzylguanidine; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Vanilmandelic Acid | 1986 |
[Clinical experience of scintigraphy with I-131-metaiodobenzylguanidine in neuroblastoma].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neuroblastoma; Pancreatic Neoplasms; Radionuclide Imaging | 1986 |
[Importance of gammagraphy using 131I-metaiodobenzylguanidine in the follow-up of neuroblastomas. Apropos of a case].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms | 1986 |
A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Female; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Orbital Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 1986 |
Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms; Thoracic Neoplasms | 1986 |
[Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Male; Middle Aged; Neuroblastoma; Radionuclide Imaging; Thyroid Neoplasms | 1986 |
Problem with mouse neuroblastoma for iodine-131 MIBG studies.
Topics: 3-Iodobenzylguanidine; Animals; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Neuroblastoma | 1987 |
[Significance of I-131 meta-iodobenzylguanidine scintigraphy in diagnosing neuroblastoma].
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1985 |
Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Topics: 3-Iodobenzylguanidine; Binding, Competitive; Biological Transport, Active; Cell Line; Humans; Iodobenzenes; Melanoma; Neuroblastoma; Norepinephrine; Osteosarcoma; Sodium | 1985 |
[Normal and pathological distribution of 131-m-iodobenzylguanidine in children. Contribution to the diagnosis of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodobenzenes; Liver Neoplasms; Male; Mediastinal Neoplasms; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms | 1985 |
Localization procedures in pheochromocytoma and neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adult; Aged; Bone Neoplasms; Carcinoid Tumor; Child; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Ultrasonography | 1985 |
[Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radiography; Radionuclide Imaging; Ultrasonography | 1985 |
Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Adult; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Sympatholytics; Whole-Body Counting | 1985 |
Radiation protection during treatment of children with 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Body Burden; Child; Child, Preschool; Female; Humans; Iodides; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Parents; Patient Isolation; Radiation Protection | 1986 |
[Diagnosis and therapy control of neuroblastoma using meta-iodo- benzylguanidine].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Half-Life; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 1985 |
Detection of neuroblastoma with 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging | 1985 |
[Use of 131I-meta-iodobenzylguanidine in pediatric oncology].
Topics: 3-Iodobenzylguanidine; Bone Marrow Diseases; Bone Neoplasms; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging | 1985 |
131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging | 1985 |
Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radionuclide Imaging; Thoracic Neoplasms | 1985 |
[Scintigraphic imaging of benign and malignant tumors of the sympathetic nervous system with meta-iodobenzylguanidine].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging | 1985 |
Coincidence of infectious osteomyelitis and disseminated neuroblastoma: a diagnostic dilemma solved by scintigraphic imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Diphosphonates; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Organotechnetium Compounds; Osteomyelitis; Radionuclide Imaging; Salmonella Infections; Technetium | 1985 |
Neuroblastoma imaged with 123I meta-iodo-benzylguanidine and with 123I-labelled monoclonal antibody, UJ13A, against neural tissue.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Bone Marrow; Bone Neoplasms; Child, Preschool; Humans; Iodine Radioisotopes; Iodobenzenes; Kidney Neoplasms; Male; Neuroblastoma; Radionuclide Imaging; Scapula | 1985 |